Molina Healthcare, Inc. (MOH)
Long Beach, CA, US
Molina Healthcare, Inc. offers comprehensive managed health care services, primarily targeting economically disadvantaged families and individuals. The company provides coverage through key government initiatives such as Medicaid and Medicare programs, in addition to state health insurance marketplaces. Its operations are strategically segmented into four main divisions: Medicaid, Medicare, Marketplace, and a general "Other" category. By the close of 2021, specifically December 31st, Molina Healthcare's network extended to approximately 5.2 million members across 18 states, all of whom qualified for Medicaid, Medicare, or other government-sponsored healthcare plans. Established in 1980, the company maintains its corporate headquarters in Long Beach, California.
No mergers or acquisitions recorded for this company.
Index membership
| Index | Added | Removed | Status |
|---|---|---|---|
| S&P 500 | 2022-03-01 | — | Active |
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.48% | -2.13% | -10.80% | +12.69% | +17.09% | +0.03% | -41.62% | -36.62% | -30.31% | +258.46% | +1,202.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 3 | 0 |
| Hold | 13 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 1 | -1 |
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 4 |
192.25
-20.8%
|
| Last Quarter | 12 |
183.92
-24.3%
|
| Last Year | 37 |
187.86
-22.7%
|
| All Time | 58 |
248.93
+2.5%
|
-
Revenue growth Medical - Healthcare Plans: +11.8%+11.8% Q1'26: -3.1% (vs Q1'25)
-
EPS growth Medical - Healthcare Plans: -1.4%-56.3% Q1'26: -95.0% (vs Q1'25)
-
FCF margin FCF growth · Medical - Healthcare Plans: +15.1%-1.6% Q1'26: +9.8% (vs Q1'25)
-
EBIT margin Medical - Healthcare Plans: +3.3%+1.7% Q1'26: +0.8% (vs Q1'25)
-
ROIC Medical - Healthcare Plans: +6.7%+16.6% ★ Q1'26: +7.3% (vs Q1'25)
-
Share dilution Medical - Healthcare Plans: +2.1%-12.0% ★ Q1'26: -6.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Plans: 0.93×4.05× ★ Q1'26: 8.09× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2004 actual |
Dec 2005 actual |
Dec 2006 actual |
Dec 2007 actual |
Dec 2008 actual |
Dec 2009 actual |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 12 Rev. Ana. 11 EPS Ana. |
Dec 2027 11 Rev. Ana. 7 EPS Ana. |
Dec 2028 10 Rev. Ana. 5 EPS Ana. |
Dec 2029 5 Rev. Ana. 1 EPS Ana. |
Dec 2030 5 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.18B
est: 1.16B (+1.6%)
|
1.65B
est: 1.48B (+11.8%)
|
2.00B
est: 1.81B (+10.5%)
|
2.49B
est: 2.24B (+11.5%)
|
3.11B
est: 2.99B (+4.1%)
|
3.67B
est: 4.03B (-8.9%)
|
4.09B
est: 3.55B (+15.2%)
|
4.77B
est: 4.31B (+10.6%)
|
6.03B
est: 4.44B (+35.8%)
|
6.59B
est: 5.75B (+14.5%)
|
9.67B
est: 11.97B (-19.2%)
|
14.07B
est: 14.13B (-0.4%)
|
17.71B
est: 17.79B (-0.5%)
|
19.88B
est: 19.87B (+0.1%)
|
18.89B
est: 18.78B (+0.6%)
|
16.83B
est: 16.83B (0.0%)
|
19.42B
est: 19.46B (-0.2%)
|
27.77B
est: 27.55B (+0.8%)
|
31.97B
est: 31.61B (+1.2%)
|
34.07B
est: 36.08B (-5.6%)
|
40.65B
est: 40.37B (+0.7%)
|
45.43B
est: 44.90B (+1.2%)
|
44.32B
42.24B – 45.24B
-1.3% YoY
|
47.74B
45.42B – 52.92B
+7.7% YoY
|
49.84B
49.69B – 49.99B
+4.4% YoY
|
50.31B
48.04B – 53.34B
+1.0% YoY
|
52.61B
50.23B – 55.78B
+4.6% YoY
|
| EBITDA |
95.26M
est: 95.01M (+0.3%)
|
60.91M
est: 47.62M (+27.9%)
|
97.29M
est: 82.42M (+18.0%)
|
126.29M
est: 107.66M (+17.3%)
|
146.29M
est: 137.89M (+6.1%)
|
93.97M
est: 100.82M (-6.8%)
|
165.77M
est: 140.21M (+18.2%)
|
210.20M
est: 140.09M (+50.1%)
|
118.32M
est: -1.34B (+108.8%)
|
214.06M
est: 227.38M (-5.9%)
|
332.70M
est: 655.73M (-49.3%)
|
514.00M
est: 443.91M (+15.8%)
|
488.00M
est: 571.30M (-14.6%)
|
-316.00M
est: -6.30B (+95.0%)
|
1.24B
est: 936.61M (+32.5%)
|
1.15B
est: 1.01B (+14.2%)
|
1.15B
est: 1.12B (+2.8%)
|
1.13B
est: 1.05B (+7.4%)
|
1.35B
est: 1.26B (+6.9%)
|
1.74B
est: 1.46B (+19.6%)
|
1.89B
est: 1.63B (+16.1%)
|
976.00M
est: 1.81B (-46.2%)
|
1.79B
1.71B – 1.83B
-1.3% YoY
|
1.93B
1.83B – 2.14B
+7.7% YoY
|
2.01B
2.01B – 2.02B
+4.4% YoY
|
2.03B
1.94B – 2.15B
+1.0% YoY
|
2.13B
2.03B – 2.25B
+4.6% YoY
|
| EBIT |
88.73M
est: 86.16M (+3.0%)
|
45.78M
est: 36.73M (+24.7%)
|
75.81M
est: 65.61M (+15.5%)
|
98.33M
est: 86.99M (+13.0%)
|
112.61M
est: 107.78M (+4.5%)
|
51.93M
est: 60.97M (-14.8%)
|
105.00M
est: 89.01M (+18.0%)
|
135.82M
est: 74.24M (+83.0%)
|
40.15M
est: -2.16B (+101.9%)
|
133.22M
est: 110.96M (+20.1%)
|
192.00M
est: 331.96M (-42.2%)
|
388.00M
est: 334.39M (+16.0%)
|
306.00M
est: 270.53M (+13.1%)
|
-494.00M
est: -7.52B (+93.4%)
|
1.11B
est: 852.21M (+30.7%)
|
1.06B
est: 915.45M (+15.7%)
|
1.06B
est: 1.04B (+2.2%)
|
995.00M
est: 949.09M (+4.8%)
|
1.17B
est: 1.14B (+3.1%)
|
1.57B
est: 1.28B (+22.5%)
|
1.71B
est: 1.44B (+18.9%)
|
781.00M
est: 1.60B (-51.1%)
|
1.58B
1.50B – 1.61B
-1.3% YoY
|
1.70B
1.62B – 1.88B
+7.7% YoY
|
1.77B
1.77B – 1.78B
+4.4% YoY
|
1.79B
1.71B – 1.90B
+1.0% YoY
|
1.87B
1.79B – 1.98B
+4.6% YoY
|
| Net Income |
55.77M
est: 54.85M (+1.7%)
|
27.60M
est: 21.93M (+25.9%)
|
45.73M
est: 39.55M (+15.6%)
|
58.33M
est: 51.63M (+13.0%)
|
62.40M
est: 59.74M (+4.4%)
|
30.87M
est: 33.24M (-7.1%)
|
54.97M
est: 46.66M (+17.8%)
|
20.82M
est: 21.52M (-3.3%)
|
9.79M
est: -1.37B (+100.7%)
|
52.93M
est: 33.89M (+56.2%)
|
62.22M
est: 88.59M (-29.8%)
|
143.00M
est: 123.68M (+15.6%)
|
8.00M
est: -80.66M (+109.9%)
|
-512.00M
est: -7.19B (+92.9%)
|
707.00M
est: 529.98M (+33.4%)
|
737.00M
est: 644.93M (+14.3%)
|
673.00M
est: 616.91M (+9.1%)
|
659.00M
est: 611.40M (+7.8%)
|
792.00M
est: 743.62M (+6.5%)
|
1.09B
est: 941.62M (+15.9%)
|
1.18B
est: 1.17B (+0.7%)
|
472.00M
est: 701.22M (-32.7%)
|
266.96M
251.85M – 282.07M
-61.9% YoY
|
463.31M
414.53M – 601.89M
+73.5% YoY
|
540.56M
480.27M – 886.99M
+16.7% YoY
|
881.58M
829.76M – 950.57M
+63.1% YoY
|
1.11B
1.04B – 1.19B
+25.7% YoY
|
| SGA |
94.15M
est: 101.23M (-7.0%)
|
163.34M
est: 147.22M (+11.0%)
|
229.06M
est: 218.48M (+4.8%)
|
285.30M
est: -202.47M (+240.9%)
|
344.76M
est: 362.57M (-4.9%)
|
399.15M
est: 454.19M (-12.1%)
|
345.99M
est: 448.92M (-22.9%)
|
415.93M
est: 551.50M (-24.6%)
|
532.63M
est: 321.92M (+65.5%)
|
666.00M
est: 889.27M (-25.1%)
|
764.69M
est: 2.07B (-63.1%)
|
1.15B
est: 1.08B (+6.4%)
|
1.39B
est: 2.53B (-45.0%)
|
1.59B
est: 14.22B (-88.8%)
|
1.33B
est: 1.08B (+23.2%)
|
1.30B
est: 1.20B (+7.6%)
|
1.48B
est: 1.87B (-21.1%)
|
2.07B
est: 1.96B (+5.5%)
|
2.31B
est: 2.26B (+2.3%)
|
2.46B
est: 2.55B (-3.3%)
|
2.74B
est: 2.85B (-3.7%)
|
3.01B
est: 3.17B (-5.0%)
|
3.13B
2.98B – 3.19B
-1.3% YoY
|
3.37B
3.20B – 3.73B
+7.7% YoY
|
3.52B
3.51B – 3.53B
+4.4% YoY
|
3.55B
3.39B – 3.76B
+1.0% YoY
|
3.71B
3.54B – 3.93B
+4.6% YoY
|
| EPS |
1.38
est: 1.30 (+6.2%)
|
0.67
est: 0.46 (+47.3%)
|
1.09
est: 0.86 (+26.7%)
|
1.37
est: 1.08 (+26.9%)
|
1.50
est: 1.38 (+8.7%)
|
0.79
est: 1.00 (-21.0%)
|
1.34
est: 0.85 (+57.6%)
|
0.45
est: 1.31 (-65.5%)
|
0.21
est: 0.98 (-78.5%)
|
1.16
est: 0.75 (+54.7%)
|
1.33
est: 1.51 (-11.9%)
|
2.75
est: 2.66 (+3.3%)
|
0.93
est: 2.78 (-66.5%)
|
-9.14
est: -4.15 (-120.1%)
|
10.61
est: 9.25 (+14.7%)
|
11.85
est: 11.58 (+2.3%)
|
11.41
est: 12.01 (-5.0%)
|
11.40
est: 13.38 (-14.8%)
|
13.70
est: 17.80 (-23.0%)
|
18.71
est: 18.36 (+1.9%)
|
20.52
est: 23.21 (-11.6%)
|
8.93
est: 13.91 (-35.8%)
|
5.19
4.96 – 5.55
-62.7% YoY
|
9.29
8.16 – 11.85
+79.2% YoY
|
12.91
9.46 – 17.46
+38.9% YoY
|
17.36
16.34 – 18.71
+34.5% YoY
|
21.81
20.53 – 23.52
+25.7% YoY
|
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-26 | Barclays | Underweight | Underweight | Maintain |
| 2026-05-22 | UBS | Neutral | Neutral | Maintain |
| 2026-05-11 | Cantor Fitzgerald | Neutral | Neutral | Maintain |
| 2026-04-27 | Wells Fargo | Equal Weight | Equal Weight | Maintain |
| 2026-04-24 | Morgan Stanley | Equal Weight | Equal Weight | Maintain |
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-27 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-26 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-22 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-21 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-20 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-19 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-18 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-15 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-14 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-13 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-12 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-11 | B+ | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-08 | B+ | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-07 | B+ | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-06 | B+ | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-05 | B+ | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-04 | B+ | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-01 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-30 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-29 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-28 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-27 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-23 | B | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-22 | B | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-15 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group - 23-1945930 | 6.45M | 10.99% | — | 74.5K | 6.26M | 188.8K | IA | Pennsylvania | 2022-04-08 | ↗ |
| 2 | Capital World Investors ** | 6.12M | 10.00% | 6.12M | — | 6.12M | — | IA | Delaware | 2020-03-10 | ↗ |
| 3 | (1) BlackRock, Inc. | 5.34M | 9.10% | 5.00M | — | 5.34M | — | HC | Delaware | 2022-02-03 | ↗ |
| 4 | 52-0556948 | 4.16M | 7.20% | 1.28M | — | — | — | IA | Maryland | 2024-02-14 | ↗ |
| 5 | Wellington Group Holdings LLP | 3.83M | 6.57% | — | 3.23M | — | — | HC | Massachusetts | 2024-02-08 | ↗ |
| 6 | Wellington Investment Advisors Holdings LLP | 3.83M | 6.57% | — | 3.23M | — | — | HC | Massachusetts | 2024-02-08 | ↗ |
| 7 | Wellington Management Group LLP | 3.83M | 6.57% | — | 3.23M | — | — | HC | Massachusetts | 2024-02-08 | ↗ |
| 8 | Abigail P. Johnson | 3.59M | 6.15% | — | — | 3.59M | — | IN | — | 2023-02-09 | ↗ |
| 9 | FMR LLC | 3.59M | 6.15% | 3.57M | — | 3.59M | — | HC | Delaware | 2023-02-09 | ↗ |
| 10 | 13-3127734 | 1.91M | 3.27% | 1.91M | — | 1.91M | — | HC | Delaware | 2022-02-10 | ↗ |
| 11 | 26-0385758 | 1.91M | 3.27% | 1.91M | — | 1.91M | — | IA | Delaware | 2022-02-10 | ↗ |
| 12 | 95-1411037 | 13.00 | 6.00% | 3.49M | — | 3.49M | — | IA | Delaware | 2024-11-12 | ↗ |
Institutional Activity (13F)
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 6.08M -353.2K (-5.5%) | 1.06B -176.0M (-14.3%) | 11.98% +0.123 pp | 0.02% -0.003 pp | USD128.26 +35.3% | 84 qtrs — |
| 2 | BLACKROCK, INC. | 3.89M -660.4K (-14.5%) | 675.47M -195.7M (-22.5%) | 7.66% -0.722 pp | 0.01% -0.004 pp | USD343.73 -49.5% | 6 qtrs — |
| 3 | CAPITAL WORLD INVESTORS | 3.50M -1.7M (-32.2%) | 608.11M -380.7M (-38.5%) | 6.90% -2.617 pp | 0.08% -0.052 pp | USD176.55 -1.7% | 50 qtrs — |
| 4 | FMR LLC | 2.98M +822.0K (+38.2%) | 516.47M +104.3M (+25.3%) | 5.86% +1.892 pp | 0.03% +0.005 pp | USD249.85 -30.5% | 35 qtrs — |
| 5 | HARRIS ASSOCIATES L P | 2.35M -335.7K (-12.5%) | 407.20M -106.1M (-20.7%) | 4.62% -0.320 pp | 0.51% -0.308 pp | USD264.88 -34.5% | 4 qtrs — |
| 6 | T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 2.17M +201.8K (+10.2%) | 376.83M -84.0K (0.0%) | 4.28% +0.648 pp | 0.24% +0.007 pp | USD279.18 -37.8% | 14 qtrs — |
| 7 | STATE STREET CORP | 2.01M -405.1K (-16.8%) | 348.50M -113.3M (-24.5%) | 3.95% -0.491 pp | 0.01% -0.004 pp | USD173.66 -0.1% | 51 qtrs — |
| 8 | INVESCO LTD. | 1.69M +329.7K (+24.2%) | 293.45M +33.0M (+12.7%) | 3.33% +0.822 pp | 0.05% +0.004 pp | USD275.79 -37.1% | 57 qtrs — |
| 9 | VICTORY CAPITAL MANAGEMENT INC | 1.41M +447.1K (+46.4%) | 244.80M +60.4M (+32.8%) | 2.78% +1.003 pp | 0.14% +0.030 pp | USD202.18 -14.2% | 45 qtrs — |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 1.40M -156.6K (-10.1%) | 242.58M -54.2M (-18.3%) | 2.76% -0.110 pp | 0.02% -0.004 pp | USD215.08 -19.3% | 78 qtrs — |
| 11 | 8 KNOTS MANAGEMENT, LLC | 1.15M +1.1M (+100.0%) | 198.94M +198.9M (+100.0%) | 2.26% +2.257 pp | 22.92% +22.917 pp | USD173.54 +0.0% | 1 qtrs NEW |
| 12 | DIMENSIONAL FUND ADVISORS LP | 1.13M +189.1K (+20.1%) | 195.70M +16.1M (+8.9%) | 2.22% +0.492 pp | 0.04% +0.003 pp | USD182.58 -5.0% | 51 qtrs — |
| 13 | WELLINGTON MANAGEMENT GROUP LLP | 1.11M +45.1K (+4.2%) | 192.56M -11.1M (-5.5%) | 2.18% +0.224 pp | 0.03% -0.002 pp | USD224.56 -22.7% | 37 qtrs — |
| 14 | PRICE T ROWE ASSOCIATES INC /MD/ | 994.3K -2.5M (-71.6%) | 172.55M -497.9M (-74.3%) | 1.96% -4.495 pp | 0.02% -0.053 pp | USD225.40 -23.0% | 45 qtrs — |
| 15 | MORGAN STANLEY | 874.9K -109.7K (-11.1%) | 151.84M -36.6M (-19.4%) | 1.72% -0.091 pp | 0.01% -0.002 pp | USD267.14 -35.0% | 51 qtrs — |
| 16 | TWO SIGMA INVESTMENTS, LP | 823.1K +737.2K (+857.6%) | 142.85M +126.4M (+768.4%) | 1.62% +1.462 pp | 0.20% +0.177 pp | USD185.76 -6.6% | 15 qtrs — |
| 17 | CAPITAL RESEARCH GLOBAL INVESTORS | 795.9K +3.1K (+0.4%) | 138.12M -13.6M (-9.0%) | 1.57% +0.107 pp | 0.03% -0.003 pp | USD321.30 -46.0% | 13 qtrs — |
| 18 | TWO SIGMA ADVISERS, LP | 671.8K +461.7K (+219.7%) | 116.58M +76.4M (+190.0%) | 1.32% +0.936 pp | 0.23% +0.146 pp | USD182.31 -4.8% | 5 qtrs — |
| 19 | MADISON AVENUE PARTNERS, LP | 633.9K +633.9K (+100.0%) | 110.00M +110.0M (+100.0%) | 1.25% +1.248 pp | 4.73% +4.726 pp | USD173.54 +0.0% | 1 qtrs NEW |
| 20 | NORGES BANK | 632.5K +632.5K (+100.0%) | 109.77M +109.8M (+100.0%) | 1.25% +1.245 pp | 0.01% +0.012 pp | USD173.54 +0.0% | 1 qtrs NEW |
| 21 | BAUPOST GROUP LLC/MA | 625.0K +625.0K (+100.0%) | 108.46M +108.5M (+100.0%) | 1.23% +1.231 pp | 2.05% +2.055 pp | USD173.54 +0.0% | 1 qtrs NEW |
| 22 | BANK OF AMERICA CORP /DE/ | 612.1K +402.3K (+191.7%) | 106.23M +66.1M (+164.6%) | 1.21% +0.819 pp | 0.01% +0.005 pp | USD222.41 -22.0% | 52 qtrs — |
| 23 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 548.1K +12.7K (+2.4%) | 95.12M -7.3M (-7.2%) | 1.08% +0.093 pp | 0.01% -0.002 pp | USD189.43 -8.4% | 89 qtrs — |
| 24 | NORTHERN TRUST CORP | 460.6K -108.5K (-19.1%) | 79.93M -29.0M (-26.6%) | 0.91% -0.141 pp | 0.01% -0.004 pp | USD153.90 +12.8% | 51 qtrs — |
| 25 | LONG FOCUS CAPITAL MANAGEMENT, LLC | 455.0K +197.5K (+76.7%) | 78.96M +29.7M (+60.3%) | 0.90% +0.422 pp | 2.08% +0.450 pp | USD183.62 -5.5% | 2 qtrs — |
| 26 | BNP PARIBAS ARBITRAGE, SNC | 439.4K +169.7K (+63.0%) | 76.25M +24.7M (+47.8%) | 0.87% +0.369 pp | 0.03% +0.007 pp | USD216.59 -19.9% | 51 qtrs — |
| 27 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 421.9K +302.9K (+254.5%) | 73.22M +50.4M (+221.5%) | 0.83% +0.612 pp | 0.01% +0.006 pp | USD188.88 -8.1% | 43 qtrs — |
| 28 | AQR CAPITAL MANAGEMENT LLC | 410.4K -2.5M (-86.0%) | 71.22M -490.3M (-87.3%) | 0.81% -4.596 pp | 0.04% -0.323 pp | USD227.09 -23.6% | 46 qtrs — |
| 29 | JACOBS LEVY EQUITY MANAGEMENT, INC | 397.8K +27.8K (+7.5%) | 69.03M -1.8M (-2.5%) | 0.78% +0.102 pp | 0.27% -0.015 pp | USD246.57 -29.6% | 84 qtrs — |
| 30 | GOLDMAN SACHS GROUP INC | 395.6K -215.6K (-35.3%) | 68.65M -48.3M (-41.3%) | 0.74% -0.388 pp | 0.01% -0.006 pp | USD248.72 -30.2% | 73 qtrs — |
| 31 | D. E. SHAW & CO., INC. | 387.1K +142.1K (+58.0%) | 67.18M +20.3M (+43.3%) | 0.76% +0.311 pp | 0.04% +0.010 pp | USD222.76 -22.1% | 42 qtrs — |
| 32 | JPMORGAN CHASE & CO | 338.8K +111.5K (+49.1%) | 58.79M +15.3M (+35.2%) | 0.67% +0.248 pp | 0.00% +0.001 pp | USD237.54 -26.9% | 51 qtrs — |
| 33 | FIERA CAPITAL CORP | 314.7K +73.1K (+30.3%) | 54.62M +8.4M (+18.1%) | 0.62% +0.175 pp | 0.17% +0.024 pp | USD235.68 -26.4% | 3 qtrs — |
| 34 | CITIGROUP INC | 277.4K +184.1K (+197.1%) | 48.15M +30.3M (+169.5%) | 0.55% +0.374 pp | 0.02% +0.013 pp | USD210.96 -17.7% | 56 qtrs — |
| 35 | ASSENAGON ASSET MANAGEMENT S.A. | 271.2K +191.7K (+241.2%) | 47.07M +31.9M (+209.4%) | 0.51% +0.360 pp | 0.06% +0.044 pp | USD182.49 -4.9% | 23 qtrs — |
| 36 | BANK OF NEW YORK MELLON CORP | 262.9K -26.3K (-9.1%) | 45.63M -9.7M (-17.6%) | 0.52% -0.015 pp | 0.01% -0.003 pp | USD105.32 +64.8% | 66 qtrs — |
| 37 | DEUTSCHE BANK AG\ | 237.9K -80.1K (-25.2%) | 41.29M -19.6M (-32.2%) | 0.47% -0.117 pp | 0.01% -0.007 pp | USD263.12 -34.0% | 50 qtrs — |
| 38 | BARCLAYS PLC | 226.4K +30.5K (+15.6%) | 39.29M -28.2M (-41.8%) | 0.45% +0.085 pp | 0.01% -0.008 pp | USD268.27 -35.3% | 51 qtrs — |
| 39 | MAPLE ROCK CAPITAL PARTNERS INC. | 226.2K +144.4K (+176.5%) | 39.25M +23.6M (+150.8%) | 0.45% +0.295 pp | 1.30% +0.679 pp | USD179.98 -3.6% | 2 qtrs — |
| 40 | INVESTMENT MANAGEMENT ASSOCIATES INC /ADV | 225.5K +119.7K (+113.2%) | 39.14M +18.9M (+93.3%) | 0.42% +0.226 pp | 10.79% +4.829 pp | USD181.90 -4.6% | 2 qtrs — |
| 41 | UBS ASSET MANAGEMENT AMERICAS INC | 225.3K -218.0K (-49.2%) | 39.09M -45.7M (-53.9%) | 0.44% -0.373 pp | 0.01% -0.010 pp | USD248.58 -30.2% | 52 qtrs — |
| 42 | LEGAL & GENERAL GROUP PLC | 210.6K -139.6K (-39.9%) | 36.55M -30.5M (-45.5%) | 0.41% -0.230 pp | 0.01% -0.007 pp | USD201.50 -13.9% | 56 qtrs — |
| 43 | DEKABANK DEUTSCHE GIROZENTRALE | 96.1K +— (+0.0%) | 36.17M +17.7M (+95.8%) | 0.19% +0.012 pp | 0.06% +0.031 pp | USD313.58 -44.7% | 31 qtrs — |
| 44 | UBS GROUP AG | 201.9K -402.0K (-66.6%) | 35.04M -80.5M (-69.7%) | 0.40% -0.715 pp | 0.01% -0.012 pp | USD218.07 -20.4% | 45 qtrs — |
| 45 | CITADEL ADVISORS LLC | 201.3K +189.5K (+1,606.1%) | 34.93M +32.7M (+1,447.2%) | 0.40% +0.375 pp | 0.01% +0.005 pp | USD180.83 -4.0% | 52 qtrs — |
| 46 | ABRDN PLC | 195.1K +59.5K (+43.9%) | 33.85M +7.7M (+29.4%) | 0.36% +0.114 pp | 0.05% +0.011 pp | USD235.07 -26.2% | 28 qtrs — |
| 47 | HSBC HOLDINGS PLC | 193.1K +68.4K (+54.9%) | 33.69M +9.8M (+40.9%) | 0.36% +0.131 pp | 0.02% +0.004 pp | USD259.26 -33.1% | 43 qtrs — |
| 48 | MILLENNIUM MANAGEMENT LLC | 192.4K +89.5K (+87.1%) | 33.38M +13.7M (+69.7%) | 0.38% +0.189 pp | 0.01% +0.006 pp | USD197.89 -12.3% | 59 qtrs — |
| 49 | TUDOR INVESTMENT CORP ET AL | 175.1K +166.6K (+1,960.1%) | 30.39M +28.8M (+1,768.3%) | 0.34% +0.329 pp | 0.06% +0.053 pp | USD178.50 -2.8% | 5 qtrs — |
| 50 | AMUNDI | 175.0K +61.0K (+53.6%) | 30.37M +7.5M (+32.9%) | 0.34% +0.135 pp | 0.01% +0.001 pp | USD253.85 -31.6% | 19 qtrs — |
| 51 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 154.6K -31.4K (-16.9%) | 26.79M -8.8M (-24.7%) | 0.30% -0.038 pp | 0.02% -0.007 pp | USD230.63 -24.8% | 51 qtrs — |
| 52 | TD ASSET MANAGEMENT INC | 152.8K +13.1K (+9.4%) | 26.52M -207.8K (-0.8%) | 0.30% +0.044 pp | 0.02% 0.000 pp | USD241.99 -28.3% | 35 qtrs — |
| 53 | FIRST TRUST ADVISORS LP | 151.5K +42.5K (+39.0%) | 26.29M +5.4M (+26.0%) | 0.30% +0.098 pp | 0.02% +0.004 pp | USD263.34 -34.1% | 31 qtrs — |
| 54 | NATIXIS | 139.0K +139.0K (+100.0%) | 24.13M +24.1M (+100.0%) | 0.27% +0.274 pp | 0.09% +0.086 pp | USD173.54 +0.0% | 21 qtrs — |
| 55 | NUVEEN, LLC | 137.0K -2.0K (-1.4%) | 23.78M -2.8M (-10.6%) | 0.27% +0.014 pp | 0.01% -0.001 pp | USD326.54 -46.9% | 4 qtrs — |
| 56 | 683 CAPITAL MANAGEMENT, LLC | 135.0K +54.0K (+66.7%) | 23.43M +7.9M (+51.1%) | 0.27% +0.117 pp | 1.02% +0.210 pp | USD184.23 -5.8% | 2 qtrs — |
| 57 | RHUMBLINE ADVISERS | 130.9K -16.8K (-11.4%) | 22.71M -5.5M (-19.6%) | 0.26% -0.014 pp | 0.02% -0.004 pp | USD203.92 -14.9% | 51 qtrs — |
| 58 | SWEDBANK AB | 127.0K +16.4K (+14.8%) | 22.04M +875.0K (+4.1%) | 0.25% +0.046 pp | 0.02% 0.000 pp | USD227.84 -23.8% | 20 qtrs — |
| 59 | WEISS ASSET MANAGEMENT LP | 126.4K +59.4K (+88.6%) | 21.93M +9.1M (+71.1%) | 0.25% +0.125 pp | 0.31% +0.157 pp | USD182.99 -5.2% | 2 qtrs — |
| 60 | THOMPSON SIEGEL & WALMSLEY LLC | 125.6K +125.6K (+100.0%) | 21.79M +21.8M (+100.0%) | 0.25% +0.247 pp | 0.37% +0.366 pp | USD173.54 +0.0% | 1 qtrs NEW |
| 61 | KOPERNIK GLOBAL INVESTORS, LLC | 125.5K +125.5K (+100.0%) | 21.79M +21.8M (+100.0%) | 0.25% +0.247 pp | 1.74% +1.740 pp | USD173.54 +0.0% | 1 qtrs NEW |
| 62 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 123.9K -34.0K (-21.5%) | 21.51M -8.7M (-28.8%) | 0.24% -0.047 pp | 0.04% -0.019 pp | USD192.79 -10.0% | 5 qtrs — |
| 63 | REDWOOD CAPITAL MANAGEMENT, LLC | 110.0K +51.6K (+88.4%) | 19.09M +7.9M (+70.8%) | 0.22% +0.109 pp | 2.04% +0.961 pp | USD183.00 -5.2% | 2 qtrs — |
| 64 | SWISS NATIONAL BANK | 106.9K -45.8K (-30.0%) | 18.55M -10.7M (-36.5%) | 0.21% -0.071 pp | 0.01% -0.006 pp | USD164.63 +5.4% | 51 qtrs — |
| 65 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 104.4K +45.6K (+77.6%) | 18.12M +6.9M (+61.1%) | 0.21% +0.097 pp | 0.01% +0.004 pp | USD257.14 -32.5% | 21 qtrs — |
| 66 | ACADIAN ASSET MANAGEMENT LLC | 104.2K -13.3K (-11.3%) | 18.07M -4.4M (-19.6%) | 0.21% -0.011 pp | 0.03% -0.010 pp | USD195.15 -11.1% | 47 qtrs — |
| 67 | SOUTH DAKOTA INVESTMENT COUNCIL | 103.3K +54.2K (+110.3%) | 17.93M +8.5M (+90.7%) | 0.20% +0.113 pp | 0.34% +0.159 pp | USD186.79 -7.1% | 41 qtrs — |
| 68 | LPL FINANCIAL LLC | 97.8K +56.0K (+133.8%) | 16.97M +9.0M (+112.0%) | 0.19% +0.116 pp | 0.00% +0.002 pp | USD207.57 -16.4% | 23 qtrs — |
| 69 | GOTHAM ASSET MANAGEMENT, LLC | 92.6K +20.7K (+28.8%) | 16.06M +2.3M (+16.8%) | 0.18% +0.050 pp | 0.06% -0.001 pp | USD205.73 -15.6% | 32 qtrs — |
| 70 | NEW YORK STATE COMMON RETIREMENT FUND | 91.0K -48.6K (-34.8%) | 15.79M -10.9M (-40.9%) | 0.18% -0.078 pp | 0.02% -0.014 pp | USD184.75 -6.1% | 73 qtrs — |
| 71 | SG AMERICAS SECURITIES, LLC | 87.2K +78.7K (+923.3%) | 15.14M +13.5M (+828.0%) | 0.16% +0.147 pp | 0.02% +0.014 pp | USD188.40 -7.9% | 51 qtrs — |
| 72 | SUMMIT STREET CAPITAL MANAGEMENT, LLC | 85.5K -58.5K (-40.6%) | 14.84M -12.7M (-46.1%) | 0.17% -0.097 pp | 2.33% -1.446 pp | USD211.22 -17.8% | 45 qtrs — |
| 73 | POINT72 ASSET MANAGEMENT, L.P. | 84.7K +84.7K (+100.0%) | 14.70M +14.7M (+100.0%) | 0.17% +0.167 pp | 0.02% +0.016 pp | USD173.54 +0.0% | 3 qtrs — |
| 74 | INVESTMENT HOUSE LLC | 84.3K +81.3K (+2,709.3%) | 14.63M +14.1M (+2,447.7%) | 0.17% +0.160 pp | 0.70% +0.668 pp | USD174.17 -0.4% | 2 qtrs — |
| 75 | STATE OF TENNESSEE, TREASURY DEPARTMENT | 79.0K +66.2K (+518.8%) | 14.19M +11.7M (+480.8%) | 0.16% +0.132 pp | 0.05% +0.037 pp | USD192.59 -9.9% | 31 qtrs — |
| 76 | QUADRATURE CAPITAL LTD | 81.4K +81.4K (+100.0%) | 14.12M +14.1M (+100.0%) | 0.16% +0.160 pp | 0.14% +0.144 pp | USD173.54 +0.0% | 7 qtrs — |
| 77 | ROYAL BANK OF CANADA | 79.5K -215.0K (-73.0%) | 13.79M -42.6M (-75.5%) | 0.16% -0.386 pp | 0.00% -0.007 pp | USD226.59 -23.4% | 51 qtrs — |
| 78 | WELLS FARGO & COMPANY/MN | 73.8K +43.2K (+141.1%) | 12.80M +6.9M (+118.7%) | 0.15% +0.089 pp | 0.00% +0.001 pp | USD195.15 -11.1% | 57 qtrs — |
| 79 | CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 69.9K -6.6K (-8.6%) | 12.13M -2.5M (-17.1%) | 0.14% -0.003 pp | 0.01% -0.002 pp | USD255.97 -32.2% | 58 qtrs — |
| 80 | SOLAS CAPITAL MANAGEMENT, LLC | 68.3K +11.6K (+20.4%) | 11.86M +998.0K (+9.2%) | 0.13% +0.030 pp | 6.73% +0.100 pp | USD188.34 -7.9% | 2 qtrs — |
| 81 | WALLEYE CAPITAL LLC | 68.3K -36.9K (-35.1%) | 11.85M -8.3M (-41.1%) | 0.13% -0.059 pp | 0.04% -0.039 pp | USD191.98 -9.6% | 12 qtrs — |
| 82 | JAIN GLOBAL LLC | 67.8K +67.8K (+100.0%) | 11.77M +11.8M (+100.0%) | 0.13% +0.134 pp | 0.06% +0.057 pp | USD173.54 +0.0% | 1 qtrs NEW |
| 83 | ALLIANCEBERNSTEIN L.P. | 67.3K -17.8K (-21.0%) | 11.68M -4.6M (-28.3%) | 0.13% -0.024 pp | 0.00% -0.001 pp | USD166.55 +4.2% | 61 qtrs — |
| 84 | JANE STREET GROUP, LLC | 65.6K +14.9K (+29.4%) | 11.38M +1.7M (+17.3%) | 0.12% +0.029 pp | 0.00% +0.000 pp | USD198.40 -12.5% | 6 qtrs — |
| 85 | RENAISSANCE TECHNOLOGIES LLC | 64.6K -255.6K (-79.8%) | 11.22M -50.1M (-81.7%) | 0.13% -0.463 pp | 0.02% -0.064 pp | USD125.43 +38.4% | 76 qtrs — |
| 86 | SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 63.8K -45.5K (-41.6%) | 11.08M -9.8M (-47.0%) | 0.13% -0.076 pp | 0.17% -0.161 pp | USD191.36 -9.3% | 2 qtrs — |
| 87 | MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 60.2K -46.5K (-43.6%) | 10.75M -9.7M (-47.4%) | 0.11% -0.084 pp | 0.01% -0.007 pp | USD311.80 -44.3% | 23 qtrs — |
| 88 | MAN GROUP PLC | 61.3K +5.1K (+9.1%) | 10.64M -114.3K (-1.1%) | 0.12% +0.017 pp | 0.02% -0.001 pp | USD287.44 -39.6% | 32 qtrs — |
| 89 | SQUAREPOINT OPS LLC | 58.9K +11.2K (+23.5%) | 10.22M +1.1M (+12.0%) | 0.12% +0.028 pp | 0.01% +0.002 pp | USD189.42 -8.4% | 14 qtrs — |
| 90 | SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 57.0K +14.0K (+32.6%) | 9.90M +1.7M (+20.4%) | 0.11% +0.033 pp | 0.04% +0.007 pp | USD260.39 -33.4% | 23 qtrs — |
| 91 | CANADA PENSION PLAN INVESTMENT BOARD | 56.6K -2.9K (-4.8%) | 9.83M -1.6M (-13.7%) | 0.11% +0.002 pp | 0.01% -0.001 pp | USD310.70 -44.1% | 19 qtrs — |
| 92 | CAPITAL FUND MANAGEMENT S.A. | 56.1K +28.1K (+100.4%) | 9.74M +4.4M (+81.7%) | 0.11% +0.059 pp | 0.03% +0.013 pp | USD182.43 -4.9% | 2 qtrs — |
| 93 | LIMESTONE INVESTMENT ADVISORS LP | 250.0K +— (+0.0%) | 253.9K +780.0 (+0.3%) | 0.49% +0.032 pp | 0.02% +0.004 pp | USD297.90 -41.7% | 3 qtrs — |
Insider Activity
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-14 | HEBERT MAURICE | Officer | S-Sale | D | Common Stock | 600 | 191.55 | 114.9K | 12,815 | D | ↗ |
| 2026-05-11 | Barlow Jeff D. | Officer | S-Sale | D | Common Stock | 17,811 | 186.12 | 3.31M | 67,175 | D | ↗ |
| 2026-05-06 | SOISTMAN FRANCIS S JR | Director | A-Award | A | Common Stock | 170 | 197.44 | 33.6K | 670 | D | ↗ |
| 2026-04-01 | ZORETIC RICHARD C | Director | A-Award | A | Common Stock | 405 | 135.82 | 55.0K | 9,152 | I | ↗ |
| 2026-04-01 | WOLF DALE B | Director | A-Award | A | Common Stock | 405 | 135.82 | 55.0K | 15,396 | I | ↗ |
| 2026-04-01 | Schapiro Richard M | Director | A-Award | A | Common Stock | 405 | 135.82 | 55.0K | 12,074 | D | ↗ |
| 2026-04-01 | ROMNEY RONNA | Director | A-Award | A | Common Stock | 405 | 135.82 | 55.0K | 17,632 | I | ↗ |
| 2026-04-01 | ORLANDO STEVEN J | Director | A-Award | A | Common Stock | 405 | 135.82 | 55.0K | 17,730 | I | ↗ |
| 2026-04-01 | Lockhart Stephen H | Director | A-Award | A | Common Stock | 405 | 135.82 | 55.0K | 4,147 | D | ↗ |
| 2026-04-01 | GROHOWSKI LEO P | Director | A-Award | A | Common Stock | 405 | 135.82 | 55.0K | 1,305 | D | ↗ |
| 2026-04-01 | BRASIER BARBARA L | Director | A-Award | A | Common Stock | 405 | 135.82 | 55.0K | 5,581 | D | ↗ |
| 2026-03-12 | ROMNEY RONNA | Director | S-Sale | D | Common Stock | 506 | 146.92 | 74.3K | 17,227 | I | ↗ |
| 2026-03-01 | Zubretsky Joseph M | Director / Officer | F-InKind | D | Common Stock | 8,597 | 154.05 | 1.32M | 32,598 | D | ↗ |
| 2026-03-01 | WOYS JAMES | Officer | A-Award | A | Common Stock | 17,016 | 145.75 | 2.48M | 90,034 | D | ↗ |
| 2026-03-01 | Keim Mark Lowell | Officer | F-InKind | D | Common Stock | 2,308 | 154.05 | 355.5K | 57,178 | D | ↗ |
| 2026-03-01 | HEBERT MAURICE | Officer | A-Award | A | Common Stock | 2,058 | 145.75 | 300.0K | 13,415 | D | ↗ |
| 2026-03-01 | Barlow Jeff D. | Officer | F-InKind | D | Common Stock | 1,638 | 154.05 | 252.3K | 71,264 | D | ↗ |
| 2026-03-01 | Bacon Debra | Officer | F-InKind | D | Common Stock | 716 | 154.05 | 110.3K | 12,190 | D | ↗ |
| 2026-02-11 | ZORETIC RICHARD C | Director | P-Purchase | A | Common Stock | 800 | 125.16 | 100.1K | 8,747 | I | ↗ |
| 2026-01-01 | ZORETIC RICHARD C | Director | A-Award | A | Common Stock | 317 | 173.54 | 55.0K | 7,947 | I | ↗ |
| 2026-01-01 | WOLF DALE B | Director | A-Award | A | Common Stock | 317 | 173.54 | 55.0K | 14,991 | I | ↗ |
| 2026-01-01 | Schapiro Richard M | Director | A-Award | A | Common Stock | 317 | 173.54 | 55.0K | 11,669 | D | ↗ |
| 2026-01-01 | ROMNEY RONNA | Director | A-Award | A | Common Stock | 317 | 173.54 | 55.0K | 17,733 | I | ↗ |
| 2026-01-01 | ORLANDO STEVEN J | Director | A-Award | A | Common Stock | 317 | 173.54 | 55.0K | 17,325 | I | ↗ |
| 2026-01-01 | Lockhart Stephen H | Director | A-Award | A | Common Stock | 317 | 173.54 | 55.0K | 3,742 | D | ↗ |
| 2026-01-01 | GROHOWSKI LEO P | Director | A-Award | A | Common Stock | 317 | 173.54 | 55.0K | 900 | D | ↗ |
| 2026-01-01 | BRASIER BARBARA L | Director | A-Award | A | Common Stock | 317 | 173.54 | 55.0K | 5,176 | D | ↗ |
| 2025-12-31 | Bacon Debra | Officer | A-Award | A | Common Stock | 22 | 147.51 | 3.2K | 12,906 | D | ↗ |
| 2025-11-24 | Schapiro Richard M | Director | S-Sale | D | Common Stock | 357 | 143.02 | 51.1K | 11,352 | D | ↗ |
| 2025-10-01 | ZORETIC RICHARD C | Director | A-Award | A | Common Stock | 285 | 192.79 | 54.9K | 7,630 | I | ↗ |
| 2025-10-01 | WOLF DALE B | Director | A-Award | A | Common Stock | 285 | 192.79 | 54.9K | 14,674 | I | ↗ |
| 2025-10-01 | Schapiro Richard M | Director | A-Award | A | Common Stock | 285 | 192.79 | 54.9K | 11,709 | D | ↗ |
| 2025-10-01 | ROMNEY RONNA | Director | A-Award | A | Common Stock | 285 | 192.79 | 54.9K | 17,416 | I | ↗ |
| 2025-10-01 | ORLANDO STEVEN J | Director | A-Award | A | Common Stock | 285 | 192.79 | 54.9K | 17,008 | I | ↗ |
| 2025-10-01 | Lockhart Stephen H | Director | A-Award | A | Common Stock | 285 | 192.79 | 54.9K | 3,425 | D | ↗ |
| 2025-10-01 | GROHOWSKI LEO P | Director | A-Award | A | Common Stock | 285 | 192.79 | 54.9K | 583 | D | ↗ |
| 2025-10-01 | BRASIER BARBARA L | Director | A-Award | A | Common Stock | 285 | 192.79 | 54.9K | 4,859 | D | ↗ |
| 2025-08-06 | ROMNEY RONNA | Director | S-Sale | D | Common Stock | 700 | 153.74 | 107.6K | 17,131 | I | ↗ |
| 2025-08-04 | WOYS JAMES | Officer | P-Purchase | A | Common Stock | 4,500 | 156.36 | 703.6K | 74,331 | D | ↗ |
| 2025-07-01 | ZORETIC RICHARD C | Director | A-Award | A | Common Stock | 180 | 306.29 | 55.1K | 7,345 | I | ↗ |
| 2025-07-01 | WOLF DALE B | Director | A-Award | A | Common Stock | 180 | 306.29 | 55.1K | 14,389 | I | ↗ |
| 2025-07-01 | Schapiro Richard M | Director | A-Award | A | Common Stock | 180 | 306.29 | 55.1K | 11,424 | D | ↗ |
| 2025-07-01 | ROMNEY RONNA | Director | A-Award | A | Common Stock | 180 | 306.29 | 55.1K | 17,831 | I | ↗ |
| 2025-07-01 | ORLANDO STEVEN J | Director | A-Award | A | Common Stock | 180 | 306.29 | 55.1K | 16,723 | I | ↗ |
| 2025-07-01 | Lockhart Stephen H | Director | A-Award | A | Common Stock | 180 | 306.29 | 55.1K | 3,140 | D | ↗ |
| 2025-07-01 | GROHOWSKI LEO P | Director | A-Award | A | Common Stock | 180 | 306.29 | 55.1K | 298 | D | ↗ |
| 2025-07-01 | Bacon Debra | Officer | F-InKind | D | Common Stock | 183 | 306.29 | 56.1K | 12,884 | D | ↗ |
| 2025-07-01 | BRASIER BARBARA L | Director | A-Award | A | Common Stock | 180 | 306.29 | 55.1K | 4,574 | D | ↗ |
| 2025-06-30 | WOYS JAMES | Officer | A-Award | A | Common Stock | 85 | 247.39 | 21.0K | 64,331 | D | ↗ |
| 2025-06-30 | Barlow Jeff D. | Officer | A-Award | A | Common Stock | 85 | 247.39 | 21.0K | 72,902 | D | ↗ |
| 2025-06-30 | Bacon Debra | Officer | A-Award | A | Common Stock | 41 | 247.39 | 10.1K | 13,067 | D | ↗ |
| 2025-05-21 | WOLF DALE B | Director | S-Sale | D | Common Stock | 100 | 320.51 | 32.1K | 15,609 | I | ↗ |
| 2025-05-05 | ORLANDO STEVEN J | Director | S-Sale | D | Common Stock | 1,000 | 318.58 | 318.6K | 16,543 | I | ↗ |
| 2025-05-01 | GROHOWSKI LEO P | Director | A-Award | A | Common Stock | 118 | 313.04 | 36.9K | 118 | D | ↗ |
| 2025-04-30 | Zubretsky Joseph M | Director / Officer | S-Sale | D | Common Stock | 86,400 | 320.00 | 27.65M | 258,815 | I | ↗ |
| 2025-04-30 | GROHOWSKI LEO P | Director | — | — | Common Stock | 0 | 0.00 | — | 0 | D | ↗ |
| 2025-04-29 | Schapiro Richard M | Director | S-Sale | D | Common Stock | 669 | 320.50 | 214.4K | 11,244 | D | ↗ |
| 2025-04-01 | ZORETIC RICHARD C | Director | A-Award | A | Common Stock | 168 | 327.71 | 55.1K | 7,165 | I | ↗ |
| 2025-04-01 | WOLF DALE B | Director | A-Award | A | Common Stock | 168 | 327.71 | 55.1K | 15,709 | D | ↗ |
| 2025-04-01 | Schapiro Richard M | Director | A-Award | A | Common Stock | 168 | 327.71 | 55.1K | 11,913 | D | ↗ |
| 2025-04-01 | ROMNEY RONNA | Director | A-Award | A | Common Stock | 168 | 327.71 | 55.1K | 17,651 | I | ↗ |
| 2025-04-01 | ORLANDO STEVEN J | Director | A-Award | A | Common Stock | 168 | 327.71 | 55.1K | 17,543 | I | ↗ |
| 2025-04-01 | Lockhart Stephen H | Director | A-Award | A | Common Stock | 168 | 327.71 | 55.1K | 2,960 | D | ↗ |
| 2025-04-01 | COOPERMAN DANIEL | Director | A-Award | A | Common Stock | 56 | 327.71 | 18.4K | 6,383 | D | ↗ |
| 2025-04-01 | BRASIER BARBARA L | Director | A-Award | A | Common Stock | 168 | 327.71 | 55.1K | 4,394 | D | ↗ |
| 2025-03-03 | ORLANDO STEVEN J | Director | S-Sale | D | Common Stock | 1,000 | 301.33 | 301.3K | 17,375 | I | ↗ |
| 2025-03-01 | Zubretsky Joseph M | Director / Officer | F-InKind | D | Common Stock | 19,993 | 301.12 | 6.02M | 372,955 | D | ↗ |
| 2025-03-01 | WOYS JAMES | Officer | F-InKind | D | Common Stock | 3,401 | 301.12 | 1.02M | 59,597 | D | ↗ |
| 2025-03-01 | Keim Mark Lowell | Officer | A-Award | A | Common Stock | 8,677 | 288.12 | 2.50M | 59,486 | D | ↗ |
| 2025-03-01 | HEBERT MAURICE | Officer | A-Award | A | Common Stock | 1,792 | 301.12 | 539.6K | 11,265 | D | ↗ |
| 2025-03-01 | Barlow Jeff D. | Officer | A-Award | A | Common Stock | 7,882 | 301.12 | 2.37M | 74,030 | D | ↗ |
| 2025-03-01 | Bacon Debra | Officer | A-Award | A | Common Stock | 6,605 | 301.12 | 1.99M | 12,673 | D | ↗ |
| 2025-01-01 | ZORETIC RICHARD C | Director | A-Award | A | Common Stock | 189 | 291.05 | 55.0K | 6,997 | I | ↗ |
| 2025-01-01 | WOLF DALE B | Director | A-Award | A | Common Stock | 189 | 291.05 | 55.0K | 15,541 | D | ↗ |
| 2025-01-01 | Schapiro Richard M | Director | A-Award | A | Common Stock | 189 | 291.05 | 55.0K | 11,745 | D | ↗ |
| 2025-01-01 | ROMNEY RONNA | Director | A-Award | A | Common Stock | 189 | 291.05 | 55.0K | 17,483 | I | ↗ |
| 2025-01-01 | ORLANDO STEVEN J | Director | A-Award | A | Common Stock | 189 | 291.05 | 55.0K | 18,375 | I | ↗ |
| 2025-01-01 | Lockhart Stephen H | Director | A-Award | A | Common Stock | 189 | 291.05 | 55.0K | 2,792 | D | ↗ |
| 2025-01-01 | COOPERMAN DANIEL | Director | A-Award | A | Common Stock | 189 | 291.05 | 55.0K | 6,327 | D | ↗ |
| 2025-01-01 | Bacon Debra | Officer | F-InKind | D | Common Stock | 450 | 291.05 | 131.0K | 6,068 | D | ↗ |
| 2025-01-01 | BRASIER BARBARA L | Director | A-Award | A | Common Stock | 189 | 291.05 | 55.0K | 4,226 | D | ↗ |
| 2024-12-31 | Bacon Debra | Officer | A-Award | A | Common Stock | 13 | 247.39 | 3.2K | 6,518 | D | ↗ |
| 2024-11-18 | Schapiro Richard M | Director | S-Sale | D | Common Stock | 136 | 292.72 | 39.8K | 11,556 | D | ↗ |
| 2024-10-01 | ZORETIC RICHARD C | Director | A-Award | A | Common Stock | 161 | 341.91 | 55.0K | 6,808 | I | ↗ |
| 2024-10-01 | WOLF DALE B | Director | A-Award | A | Common Stock | 161 | 341.91 | 55.0K | 15,352 | D | ↗ |
| 2024-10-01 | Schapiro Richard M | Director | A-Award | A | Common Stock | 161 | 341.91 | 55.0K | 11,692 | D | ↗ |
| 2024-10-01 | ROMNEY RONNA | Director | A-Award | A | Common Stock | 161 | 341.91 | 55.0K | 17,294 | I | ↗ |
| 2024-10-01 | ORLANDO STEVEN J | Director | A-Award | A | Common Stock | 161 | 341.91 | 55.0K | 18,186 | I | ↗ |
| 2024-10-01 | Lockhart Stephen H | Director | A-Award | A | Common Stock | 161 | 341.91 | 55.0K | 2,603 | D | ↗ |
| 2024-10-01 | COOPERMAN DANIEL | Director | A-Award | A | Common Stock | 161 | 341.91 | 55.0K | 6,138 | D | ↗ |
| 2024-10-01 | BRASIER BARBARA L | Director | A-Award | A | Common Stock | 161 | 341.91 | 55.0K | 4,037 | D | ↗ |
| 2024-08-15 | HEBERT MAURICE | Officer | S-Sale | D | Common Stock | 393 | 346.52 | 136.2K | 9,473 | — | ↗ |
| 2024-07-30 | ORLANDO STEVEN J | Director | S-Sale | D | Common Stock | 1,000 | 339.21 | 339.2K | 18,025 | — | ↗ |
| 2024-07-29 | Barlow Jeff D. | Officer | S-Sale | D | Common Stock | 5,340 | 335.00 | 1.79M | 66,148 | — | ↗ |
| 2024-07-01 | ZORETIC RICHARD C | Director | A-Award | A | Common Stock | 188 | 292.16 | 54.9K | 6,647 | — | ↗ |
| 2024-07-01 | WOLF DALE B | Director | A-Award | A | Common Stock | 188 | 292.16 | 54.9K | 15,191 | — | ↗ |
| 2024-07-01 | Schapiro Richard M | Director | A-Award | A | Common Stock | 188 | 292.16 | 54.9K | 11,531 | — | ↗ |
| 2024-07-01 | ROMNEY RONNA | Director | A-Award | A | Common Stock | 188 | 292.16 | 54.9K | 17,133 | — | ↗ |
| 2024-07-01 | ORLANDO STEVEN J | Director | A-Award | A | Common Stock | 188 | 292.16 | 54.9K | 19,025 | — | ↗ |
| 2024-07-01 | Lockhart Stephen H | Director | A-Award | A | Common Stock | 188 | 292.16 | 54.9K | 2,442 | — | ↗ |
| 2024-07-01 | COOPERMAN DANIEL | Director | A-Award | A | Common Stock | 188 | 292.16 | 54.9K | 5,977 | — | ↗ |
| 2024-07-01 | Bacon Debra | Officer | F-InKind | D | Common Stock | 184 | 292.16 | 53.8K | 6,505 | — | ↗ |
| 2024-07-01 | BRASIER BARBARA L | Director | A-Award | A | Common Stock | 188 | 292.16 | 54.9K | 3,876 | — | ↗ |
| 2024-06-28 | WOYS JAMES | Officer | A-Award | A | Common Stock | 69 | 252.71 | 17.4K | 53,682 | — | ↗ |
| 2024-06-28 | Barlow Jeff D. | Officer | A-Award | A | Common Stock | 69 | 252.71 | 17.4K | 71,488 | — | ↗ |
| 2024-06-28 | Bacon Debra | Officer | A-Award | A | Common Stock | 13 | 252.71 | 3.3K | 6,689 | — | ↗ |
| 2024-05-22 | WOYS JAMES | Officer | S-Sale | D | Common Stock | 1,450 | 344.32 | 499.3K | 61,413 | — | ↗ |
| 2024-05-21 | ROMNEY RONNA | Director | S-Sale | D | Common Stock | 250 | 343.27 | 85.8K | 16,945 | — | ↗ |
| 2024-04-01 | ZORETIC RICHARD C | Director | A-Award | A | Common Stock | 136 | 404.20 | 55.0K | 6,459 | — | ↗ |
| 2024-04-01 | WOLF DALE B | Director | A-Award | A | Common Stock | 136 | 404.20 | 55.0K | 15,003 | — | ↗ |
| 2024-04-01 | Schapiro Richard M | Director | A-Award | A | Common Stock | 136 | 404.20 | 55.0K | 11,343 | — | ↗ |
| 2024-04-01 | ROMNEY RONNA | Director | A-Award | A | Common Stock | 136 | 404.20 | 55.0K | 17,195 | — | ↗ |
| 2024-04-01 | ORLANDO STEVEN J | Director | A-Award | A | Common Stock | 136 | 404.20 | 55.0K | 18,837 | — | ↗ |
| 2024-04-01 | Lockhart Stephen H | Director | A-Award | A | Common Stock | 136 | 404.20 | 55.0K | 2,254 | — | ↗ |
| 2024-04-01 | COOPERMAN DANIEL | Director | A-Award | A | Common Stock | 136 | 404.20 | 55.0K | 5,789 | — | ↗ |
| 2024-04-01 | BRASIER BARBARA L | Director | A-Award | A | Common Stock | 136 | 404.20 | 55.0K | 3,688 | — | ↗ |
| 2024-03-01 | Zubretsky Joseph M | Director / Officer | A-Award | A | Common Stock | 68,844 | 387.21 | 26.66M | 392,660 | — | ↗ |
| 2024-03-01 | WOYS JAMES | Officer | A-Award | A | Common Stock | 11,473 | 387.21 | 4.44M | 64,902 | — | ↗ |
| 2024-03-01 | Keim Mark Lowell | Officer | A-Award | A | Common Stock | 16,063 | 387.21 | 6.22M | 52,594 | — | ↗ |
| 2024-03-01 | HEBERT MAURICE | Officer | F-InKind | D | Common Stock | 450 | 387.21 | 174.2K | 9,608 | — | ↗ |
| 2024-03-01 | Barlow Jeff D. | Officer | F-InKind | D | Common Stock | 2,205 | 387.21 | 853.8K | 68,113 | — | ↗ |
| 2024-03-01 | Bacon Debra | Officer | F-InKind | D | Common Stock | 170 | 387.21 | 65.8K | 6,676 | — | ↗ |
| 2024-02-20 | Schapiro Richard M | Director | S-Sale | D | Common Stock | 180 | 402.03 | 72.4K | 11,227 | — | ↗ |
| 2024-02-15 | WOLF DALE B | Director | S-Sale | D | Common Stock | 1,500 | 398.38 | 597.6K | 14,867 | — | ↗ |
| 2024-02-15 | ORLANDO STEVEN J | Director | S-Sale | D | Common Stock | 750 | 399.12 | 299.3K | 18,701 | — | ↗ |
| 2024-02-14 | Bacon Debra | Officer | S-Sale | D | Common Stock | 500 | 396.22 | 198.1K | 4,573 | — | ↗ |
| 2024-02-12 | Schapiro Richard M | Director | S-Sale | D | Common Stock | 120 | 384.54 | 46.1K | 12,207 | — | ↗ |
| 2024-02-12 | Keim Mark Lowell | Officer | S-Sale | D | Common Stock | 1,815 | 384.58 | 698.0K | 38,647 | — | ↗ |
| 2024-01-24 | Bacon Debra | Officer | — | D | Common Stock | 0 | 0.00 | — | 5,073 | — | ↗ |
| 2024-01-01 | ZORETIC RICHARD C | Director | A-Award | A | Common Stock | 152 | 361.31 | 54.9K | 6,323 | — | ↗ |
| 2024-01-01 | WOLF DALE B | Director | A-Award | A | Common Stock | 152 | 361.31 | 54.9K | 16,367 | — | ↗ |
| 2024-01-01 | Schapiro Richard M | Director | A-Award | A | Common Stock | 152 | 361.31 | 54.9K | 12,918 | — | ↗ |
| 2024-01-01 | ROMNEY RONNA | Director | A-Award | A | Common Stock | 152 | 361.31 | 54.9K | 17,059 | — | ↗ |
| 2024-01-01 | ORLANDO STEVEN J | Director | A-Award | A | Common Stock | 152 | 361.31 | 54.9K | 19,451 | — | ↗ |
| 2024-01-01 | Lockhart Stephen H | Director | A-Award | A | Common Stock | 152 | 361.31 | 54.9K | 2,118 | — | ↗ |
| 2024-01-01 | COOPERMAN DANIEL | Director | A-Award | A | Common Stock | 152 | 361.31 | 54.9K | 5,653 | — | ↗ |
| 2024-01-01 | BRASIER BARBARA L | Director | A-Award | A | Common Stock | 152 | 361.31 | 54.9K | 3,552 | — | ↗ |
| 2023-11-29 | ROMNEY RONNA | Director | S-Sale | D | Common Stock | 335 | 358.00 | 119.9K | 16,907 | — | ↗ |
| 2023-11-21 | Zubretsky Joseph M | Director / Officer | G-Gift | D | Common Stock | 5,700 | 0.00 | — | 323,816 | — | ↗ |
| 2023-10-30 | ORLANDO STEVEN J | Director | S-Sale | D | Common Stock | 1,134 | 325.96 | 369.6K | 19,299 | — | ↗ |
| 2023-10-01 | ZORETIC RICHARD C | Director | A-Award | A | Common Stock | 168 | 327.89 | 55.1K | 6,171 | — | ↗ |
| 2023-10-01 | WOLF DALE B | Director | A-Award | A | Common Stock | 168 | 327.89 | 55.1K | 16,215 | — | ↗ |
| 2023-10-01 | Schapiro Richard M | Director | A-Award | A | Common Stock | 168 | 327.89 | 55.1K | 12,766 | — | ↗ |
| 2023-10-01 | ROMNEY RONNA | Director | A-Award | A | Common Stock | 168 | 327.89 | 55.1K | 17,242 | — | ↗ |
| 2023-10-01 | ORLANDO STEVEN J | Director | A-Award | A | Common Stock | 168 | 327.89 | 55.1K | 20,433 | — | ↗ |
| 2023-10-01 | Lockhart Stephen H | Director | A-Award | A | Common Stock | 168 | 327.89 | 55.1K | 1,966 | — | ↗ |
| 2023-10-01 | COOPERMAN DANIEL | Director | A-Award | A | Common Stock | 168 | 327.89 | 55.1K | 5,501 | — | ↗ |
| 2023-10-01 | BRASIER BARBARA L | Director | A-Award | A | Common Stock | 168 | 327.89 | 55.1K | 3,400 | — | ↗ |
| 2023-09-13 | HEBERT MAURICE | Officer | S-Sale | D | Common Stock | 692 | 328.15 | 227.1K | 8,528 | — | ↗ |
| 2023-08-07 | Russo Marc | Officer | S-Sale | D | Common Stock | 2,523 | 312.72 | 789.0K | 37,093 | — | ↗ |
| 2023-08-04 | ORLANDO STEVEN J | Director | S-Sale | D | Common Stock | 723 | 301.25 | 217.8K | 20,265 | — | ↗ |
| 2023-08-01 | Barlow Jeff D. | Officer | S-Sale | D | Common Stock | 6,733 | 302.57 | 2.04M | 70,740 | — | ↗ |
| 2023-07-31 | BRASIER BARBARA L | Director | S-Sale | D | Common Stock | 1,500 | 303.89 | 455.8K | 3,232 | — | ↗ |
| 2023-07-01 | ZORETIC RICHARD C | Director | A-Award | A | Common Stock | 183 | 301.24 | 55.1K | 6,003 | — | ↗ |
| 2023-07-01 | WOLF DALE B | Director | A-Award | A | Common Stock | 183 | 301.24 | 55.1K | 16,047 | — | ↗ |
| 2023-07-01 | Schapiro Richard M | Director | A-Award | A | Common Stock | 183 | 301.24 | 55.1K | 12,598 | — | ↗ |
| 2023-07-01 | ROMNEY RONNA | Director | A-Award | A | Common Stock | 183 | 301.24 | 55.1K | 17,074 | — | ↗ |
| 2023-07-01 | ORLANDO STEVEN J | Director | A-Award | A | Common Stock | 183 | 301.24 | 55.1K | 20,988 | — | ↗ |
| 2023-07-01 | Lockhart Stephen H | Director | A-Award | A | Common Stock | 183 | 301.24 | 55.1K | 1,798 | — | ↗ |
| 2023-07-01 | COOPERMAN DANIEL | Director | A-Award | A | Common Stock | 183 | 301.24 | 55.1K | 5,333 | — | ↗ |
| 2023-07-01 | BRASIER BARBARA L | Director | A-Award | A | Common Stock | 183 | 301.24 | 55.1K | 4,732 | — | ↗ |
| 2023-06-30 | WOYS JAMES | Officer | A-Award | A | Common Stock | 75 | 301.24 | 22.6K | 53,429 | — | ↗ |
| 2023-06-30 | Barlow Jeff D. | Officer | A-Award | A | Common Stock | 75 | 301.24 | 22.6K | 77,473 | — | ↗ |
| 2023-04-01 | ZORETIC RICHARD C | Director | A-Award | A | Common Stock | 206 | 267.49 | 55.1K | 5,820 | — | ↗ |
| 2023-04-01 | WOLF DALE B | Director | A-Award | A | Common Stock | 206 | 267.49 | 55.1K | 15,864 | — | ↗ |
| 2023-04-01 | Schapiro Richard M | Director | A-Award | A | Common Stock | 206 | 267.49 | 55.1K | 12,415 | — | ↗ |
| 2023-04-01 | Russo Marc | Officer | F-InKind | D | Common Stock | 2,179 | 267.49 | 582.9K | 39,616 | — | ↗ |
| 2023-04-01 | ROMNEY RONNA | Director | A-Award | A | Common Stock | 206 | 267.49 | 55.1K | 16,891 | — | ↗ |
| 2023-04-01 | ORLANDO STEVEN J | Director | A-Award | A | Common Stock | 206 | 267.49 | 55.1K | 20,805 | — | ↗ |
| 2023-04-01 | Lockhart Stephen H | Director | A-Award | A | Common Stock | 206 | 267.49 | 55.1K | 1,615 | — | ↗ |
| 2023-04-01 | COOPERMAN DANIEL | Director | A-Award | A | Common Stock | 206 | 267.49 | 55.1K | 5,150 | — | ↗ |
| 2023-04-01 | BRASIER BARBARA L | Director | A-Award | A | Common Stock | 206 | 267.49 | 55.1K | 4,549 | — | ↗ |
| 2023-03-03 | COOPERMAN DANIEL | Director | M-Exempt | A | Common Stock | 5,000 | 33.02 | 165.1K | 9,944 | — | ↗ |
| 2023-03-01 | Zubretsky Joseph M | Director / Officer | A-Award | A | Common Stock | 134,638 | 273.80 | 36.86M | 393,628 | — | ↗ |
| 2023-03-01 | WOYS JAMES | Officer | F-InKind | D | Common Stock | 1,446 | 273.80 | 395.9K | 36,364 | — | ↗ |
| 2023-03-01 | Russo Marc | Officer | F-InKind | D | Common Stock | 1,171 | 273.80 | 320.6K | 14,342 | — | ↗ |
| 2023-03-01 | Keim Mark Lowell | Officer | F-InKind | D | Common Stock | 2,851 | 273.08 | 778.6K | 31,962 | — | ↗ |
| 2023-03-01 | HEBERT MAURICE | Officer | F-InKind | D | Common Stock | 847 | 273.80 | 231.9K | 9,220 | — | ↗ |
| 2023-03-01 | Barlow Jeff D. | Officer | F-InKind | D | Common Stock | 3,700 | 273.80 | 1.01M | 62,430 | — | ↗ |
| 2023-01-01 | ZORETIC RICHARD C | Director | A-Award | A | Common Stock | 167 | 330.22 | 55.1K | 5,614 | — | ↗ |
| 2023-01-01 | WOLF DALE B | Director | A-Award | A | Common Stock | 167 | 330.22 | 55.1K | 15,658 | — | ↗ |
| 2023-01-01 | Schapiro Richard M | Director | A-Award | A | Common Stock | 167 | 330.22 | 55.1K | 12,209 | — | ↗ |
| 2023-01-01 | ROMNEY RONNA | Director | A-Award | A | Common Stock | 167 | 330.22 | 55.1K | 16,685 | — | ↗ |
| 2023-01-01 | ORLANDO STEVEN J | Director | A-Award | A | Common Stock | 167 | 330.22 | 55.1K | 20,599 | — | ↗ |
| 2023-01-01 | Lockhart Stephen H | Director | A-Award | A | Common Stock | 167 | 330.22 | 55.1K | 1,409 | — | ↗ |
| 2023-01-01 | COOPERMAN DANIEL | Director | A-Award | A | Common Stock | 167 | 330.22 | 55.1K | 4,944 | — | ↗ |
| 2023-01-01 | BRASIER BARBARA L | Director | A-Award | A | Common Stock | 167 | 330.22 | 55.1K | 4,343 | — | ↗ |
| 2022-12-12 | Russo Marc | Officer | S-Sale | D | Common Stock | 1,500 | 351.17 | 526.8K | 15,513 | — | ↗ |
| 2022-12-07 | WOLF DALE B | Director | S-Sale | D | Common Stock | 50 | 341.30 | 17.1K | 15,491 | — | ↗ |
| 2022-11-29 | Zubretsky Joseph M | Officer | G-Gift | D | Common Stock | 4,600 | 0.00 | — | 250,557 | — | ↗ |
| 2022-11-07 | WOLF DALE B | Director | M-Exempt | D | Stock Option (Right to Buy) | 6,000 | 33.02 | 198.1K | 0 | — | ↗ |
| 2022-11-07 | ROMNEY RONNA | Director | S-Sale | D | Common Stock | 150 | 331.56 | 49.7K | 16,518 | — | ↗ |
| 2022-10-31 | Schapiro Richard M | Director | S-Sale | D | Common Stock | 2,800 | 354.61 | 992.9K | 12,242 | — | ↗ |
| 2022-10-07 | Zubretsky Joseph M | Officer | S-Sale | D | Common Stock | 1,412 | 348.85 | 492.6K | 255,157 | — | ↗ |
| 2022-10-06 | Zubretsky Joseph M | Officer | S-Sale | D | Common Stock | 9,423 | 354.61 | 3.34M | 267,834 | — | ↗ |
| 2022-10-05 | Zubretsky Joseph M | Officer | M-Exempt | D | Stock Option (Right to Buy) | 30,000 | 0.00 | — | 58,914 | — | ↗ |
| 2022-10-04 | Zubretsky Joseph M | Officer | S-Sale | D | Common Stock | 7,873 | 344.66 | 2.71M | 264,160 | — | ↗ |
| 2022-10-03 | Zubretsky Joseph M | Officer | S-Sale | D | Common Stock | 4,505 | 338.90 | 1.53M | 258,535 | — | ↗ |
| 2022-10-01 | ZORETIC RICHARD C | Director | A-Award | A | Common Stock | 167 | 329.84 | 55.1K | 5,447 | — | ↗ |
| 2022-10-01 | WOLF DALE B | Director | A-Award | A | Common Stock | 167 | 329.84 | 55.1K | 11,991 | — | ↗ |
Executive team
Executive compensation
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Joseph M. Zubretsky President and Chief Executive Officer | 1.60M | — | 16.20M | — | — | 540.8K | 18.34M | 88.33% | ↗ |
| 2 | 2025 | Mark L. Keim Chief Financial Officer | 1.00M | — | 6.25M | — | — | 312.0K | 7.56M | 82.65% | ↗ |
| 3 | 2025 | James E. Woys Chief Operating Officer | 800.0K | — | 4.50M | — | — | 56.4K | 5.36M | 84.01% | ↗ |
| 4 | 2025 | Jeff D. Barlow Chief Legal Officer and Secretary | 685.0K | — | 3.50M | — | — | 210.3K | 4.40M | 79.63% | ↗ |
| 5 | 2025 | Debra J. Bacon Executive Vice President, Medicaid | 675.0K | — | 2.20M | — | — | 56.7K | 2.93M | 75.04% | ↗ |
| 6 | 2024 | Joseph M. Zubretsky President and Chief Executive Officer | 1.60M | — | 16.20M | — | 3.36M | 784.0K | 21.94M | 73.82% | ↗ |
| 7 | 2024 | Mark L. Keim Chief Financial Officer | 850.0K | — | 5.00M | — | 892.5K | 303.3K | 7.05M | 70.96% | ↗ |
| 8 | 2024 | James E. Woys Chief Operating Officer | 800.0K | — | 4.50M | — | 840.0K | 56.5K | 6.20M | 72.62% | ↗ |
| 9 | 2024 | Jeff D. Barlow Chief Legal Officer and Secretary | 685.0K | — | 3.20M | — | 719.3K | 226.0K | 4.83M | 66.25% | ↗ |
| 10 | 2024 | Debra J. Bacon Executive Vice President, Medicaid | 675.0K | — | 2.20M | — | 708.8K | 52.2K | 3.64M | 60.51% | ↗ |
| 11 | 2023 | Joseph M. Zubretsky President and Chief Executive Officer | 1.50M | — | 15.50M | — | 4.41M | 81.6K | 21.49M | 72.12% | ↗ |
| 12 | 2023 | Mark L. Keim Chief Financial Officer | 850.0K | — | 4.00M | — | 1.25M | 302.6K | 6.40M | 62.48% | ↗ |
| 13 | 2023 | James E. Woys Chief Operating Officer | 800.0K | — | 3.50M | — | 1.18M | 61.1K | 5.54M | 63.21% | ↗ |
| 14 | 2023 | Marc S. Russo Former Executive Vice President of Health Plans | 641.3K | — | 3.25M | — | — | 1.55M | 5.44M | 59.78% | ↗ |
| 15 | 2023 | Jeff D. Barlow Chief Legal Officer and Secretary | 685.0K | — | 3.00M | — | 1.01M | 197.1K | 4.89M | 61.36% | ↗ |
| 16 | 2023 | Maurice S. Hebert Chief Accounting Officer | 425.0K | — | 400.0K | — | 371.9K | 74.8K | 1.27M | 31.46% | ↗ |
| 17 | 2022 | Joseph M. Zubretsky President and Chief Executive Officer | 1.50M | — | 15.00M | — | 5.55M | 81.4K | 22.13M | 67.78% | ↗ |
| 18 | 2022 | Mark L. Keim Chief Financial Officer | 850.0K | — | 3.75M | — | 1.57M | 302.4K | 6.47M | 57.92% | ↗ |
| 19 | 2022 | James E. Woys Executive Vice President of Health Plan Services | 800.0K | — | 3.25M | — | 1.48M | 54.0K | 5.58M | 58.20% | ↗ |
| 20 | 2022 | James E. Woys Chief Operating Officer | 800.0K | — | 3.25M | — | 1.48M | 54.0K | 5.58M | 58.20% | ↗ |
| 21 | 2022 | Marc S. Russo Former Executive Vice President of Health Plans | 700.0K | — | 2.75M | — | 1.30M | 17.5K | 4.76M | 57.74% | ↗ |
| 22 | 2022 | Marc S. Russo Executive Vice President of Health Plans | 700.0K | — | 2.75M | — | 1.30M | 17.5K | 4.76M | 57.74% | ↗ |
| 23 | 2022 | Jeff D. Barlow Chief Legal Officer and Secretary | 685.0K | — | 2.75M | — | 1.27M | 47.3K | 4.75M | 57.90% | ↗ |
| 24 | 2021 | Joseph M. Zubretsky President and Chief Executive Officer | 1.50M | — | 15.00M | — | 3.38M | 86.6K | 19.96M | 75.14% | ↗ |
| 25 | 2021 | Mark L. Keim Chief Financial Officer | 850.0K | — | 3.50M | — | 1.28M | 301.8K | 5.93M | 59.05% | ↗ |
| 26 | 2021 | James E. Woys Chief Operating Officer | 750.0K | — | 2.50M | — | 1.13M | 141.4K | 4.52M | 55.35% | ↗ |
| 27 | 2021 | James E. Woys Executive Vice President of Health Plan Services | 750.0K | — | 2.50M | — | 1.13M | 141.4K | 4.52M | 55.35% | ↗ |
| 28 | 2021 | Jeff D. Barlow Chief Legal Officer and Secretary | 650.0K | — | 2.50M | — | 975.0K | 196.6K | 4.32M | 57.85% | ↗ |
| 29 | 2021 | Marc S. Russo Former Executive Vice President of Health Plans | 700.0K | — | 2.25M | — | 1.05M | 16.9K | 4.02M | 56.01% | ↗ |
| 30 | 2021 | Marc S. Russo Executive Vice President of Health Plans | 700.0K | — | 2.25M | — | 1.05M | 16.9K | 4.02M | 56.01% | ↗ |
| 31 | 2021 | Thomas L. Tran Former Chief Financial Officer | 312.3K | — | — | — | — | 1.89M | 2.20M | 0.00% | ↗ |
| 32 | 2020 | Joseph M. Zubretsky President and Chief Executive Officer | 1.30M | — | 13.75M | — | 2.69M | 71.3K | 17.81M | 77.19% | ↗ |
| 33 | 2020 | Marc S. Russo Executive Vice President of Health Plans | 487.5K | 537.5K | 4.62M | — | 525.0K | 14.9K | 6.19M | 74.72% | ↗ |
| 34 | 2020 | Jeff D. Barlow Chief Legal Officer and Secretary | 600.0K | — | 3.18M | — | 828.0K | 140.2K | 4.74M | 66.94% | ↗ |
| 35 | 2020 | Mark L. Keim Chief Financial Officer | 640.4K | — | 2.50M | — | 725.0K | 296.2K | 4.16M | 60.07% | ↗ |
| 36 | 2020 | James E. Woys Executive Vice President of Health Plan Services | 750.0K | — | 2.00M | — | 724.5K | 181.9K | 3.66M | 54.70% | ↗ |
| 37 | 2020 | Thomas L. Tran Former Chief Financial Officer | 700.0K | — | 1.50M | — | 966.0K | 223.5K | 3.39M | 44.25% | ↗ |
| 38 | 2019 | Joseph M. Zubretsky President and Chief Executive Officer | 1.30M | — | 13.00M | — | 3.71M | 20.0K | 18.03M | 72.12% | ↗ |
| 39 | 2019 | Thomas L. Tran Former Chief Financial Officer | 700.0K | — | 2.00M | — | 1.05M | 240.6K | 3.99M | 50.12% | ↗ |
| 40 | 2019 | Thomas L. Tran Chief Financial Officer | 700.0K | — | 2.00M | — | 1.05M | 240.6K | 3.99M | 50.12% | ↗ |
| 41 | 2019 | James E. Woys Executive Vice President of Health Plan Services | 750.0K | — | 2.00M | — | 997.5K | 163.1K | 3.91M | 51.14% | ↗ |
| 42 | 2019 | Jeff D. Barlow Chief Legal Officer and Secretary | 600.0K | — | 2.00M | — | 1.14M | 97.2K | 3.84M | 52.12% | ↗ |
| 43 | 2019 | Pamela S. Sedmak Former Executive Vice President of Health Plan Operations | 750.0K | — | 2.00M | — | 735.0K | 102.9K | 3.59M | 55.74% | ↗ |
| 44 | 2018 | Joseph M. Zubretsky President and Chief Executive Officer | 1.30M | — | 10.00M | — | 3.90M | 19.8K | 15.22M | 65.70% | ↗ |
| 45 | 2018 | Jeff D. Barlow Chief Legal Officer and Secretary | 599.0K | — | 2.50M | — | 1.20M | 39.0K | 4.34M | 57.63% | ↗ |
| 46 | 2018 | Mark L. Keim Executive Vice President of Strategic Planning and Corporate Development | 507.7K | 1.84M | 750.0K | — | 746.7K | 14.4K | 3.86M | 19.41% | ↗ |
| 47 | 2018 | Joseph W. White Former Chief Financial Officer | 295.0K | — | 1.90M | — | — | 1.64M | 3.84M | 49.48% | ↗ |
| 48 | 2018 | Thomas L. Tran Former Chief Financial Officer | 409.2K | 126.7K | 2.00M | — | 933.3K | 14.8K | 3.48M | 57.41% | ↗ |
| 49 | 2018 | Thomas L. Tran Chief Financial Officer | 409.2K | 126.7K | 2.00M | — | 933.3K | 14.8K | 3.48M | 57.41% | ↗ |
| 50 | 2018 | Pamela S. Sedmak Former Executive Vice President of Health Plan Operations | 576.9K | 160.0K | 750.0K | — | 910.0K | 12.1K | 2.41M | 31.13% | ↗ |
| 51 | 2018 | Pamela S. Sedmak Executive Vice President of Health Plan Operations | 576.9K | 160.0K | 750.0K | — | 910.0K | 12.1K | 2.41M | 31.13% | ↗ |
| 52 | 2017 | Joseph M. Zubretsky President and Chief Executive Officer | 175.0K | 4.00M | — | 15.54M | — | 27.9K | 19.74M | 78.71% | ↗ |
| 53 | 2017 | Dr. J. Mario Molina Former President and Chief Executive Officer | 440.8K | — | 9.94M | — | — | 6.61M | 17.00M | 58.50% | ↗ |
| 54 | 2017 | John C. Molina Former Chief Financial Officer | 318.0K | — | 3.42M | — | — | 4.28M | 8.01M | 42.66% | ↗ |
| 55 | 2017 | Joseph W. White Former Chief Financial Officer | 1.25M | — | 3.36M | — | — | 43.1K | 4.65M | 72.25% | ↗ |
| 56 | 2017 | Joseph W. White Chief Financial Officer and former Interim Chief Executive Officer | 1.25M | — | 3.36M | — | — | 43.1K | 4.65M | 72.25% | ↗ |
| 57 | 2017 | Terry P. Bayer Former Chief Operating Officer | 700.0K | — | 2.73M | — | — | 199.0K | 3.63M | 75.26% | ↗ |
| 58 | 2017 | Jeff D. Barlow Chief Legal Officer and Secretary | 550.0K | — | 1.62M | — | — | 60.7K | 2.23M | 72.57% | ↗ |
| 59 | 2017 | Lisa A. Rubino Former Sr. Vice President of Medicare & Duals Integration | 500.0K | — | 600.0K | — | — | 76.5K | 1.18M | 51.00% | ↗ |
| 60 | 2016 | Dr. J. Mario Molina Former President and Chief Executive Officer | 1.17M | — | 8.44M | — | 255.0K | 180.9K | 10.05M | 84.02% | ↗ |
| 61 | 2016 | Dr. J. Mario Molina President and Chief Executive Officer | 1.17M | — | 8.44M | — | 255.0K | 180.9K | 10.05M | 84.02% | ↗ |
| 62 | 2016 | John C. Molina Former Chief Financial Officer | 878.0K | — | 4.26M | — | 180.0K | 66.1K | 5.38M | 79.12% | ↗ |
| 63 | 2016 | John C. Molina Chief Financial Officer | 878.0K | — | 4.26M | — | 180.0K | 66.1K | 5.38M | 79.12% | ↗ |
| 64 | 2016 | Terry P. Bayer Chief Operating Officer | 644.0K | — | 3.33M | — | 110.0K | 97.5K | 4.18M | 79.62% | ↗ |
| 65 | 2016 | Terry P. Bayer Former Chief Operating Officer | 644.0K | — | 3.33M | — | 110.0K | 97.5K | 4.18M | 79.62% | ↗ |
| 66 | 2016 | Joseph W. White Chief Accounting Officer | 538.0K | — | 2.79M | — | 80.0K | 16.4K | 3.42M | 81.45% | ↗ |
| 67 | 2016 | Joseph W. White Former Chief Financial Officer | 538.0K | — | 2.79M | — | 80.0K | 16.4K | 3.42M | 81.45% | ↗ |
| 68 | 2016 | Joseph W. White Chief Financial Officer and former Interim Chief Executive Officer | 538.0K | — | 2.79M | — | 80.0K | 16.4K | 3.42M | 81.45% | ↗ |
| 69 | 2016 | Jeff D. Barlow Chief Legal Officer and Secretary | 525.0K | — | 2.02M | — | 75.0K | 41.9K | 2.66M | 75.89% | ↗ |
| 70 | 2015 | Dr. J. Mario Molina Former President and Chief Executive Officer | 1.05M | — | 7.89M | — | 1.31M | 15.5K | 10.27M | 76.90% | ↗ |
| 71 | 2015 | J. Mario Molina, M.D. President and Chief Executive Officer | 1.05M | — | 7.89M | — | 1.31M | 15.5K | 10.27M | 76.90% | ↗ |
| 72 | 2015 | Dr. J. Mario Molina President and Chief Executive Officer | 1.05M | — | 7.89M | — | 1.31M | 15.5K | 10.27M | 76.90% | ↗ |
| 73 | 2015 | John C. Molina Chief Financial Officer | 878.0K | — | 2.61M | — | 910.3K | 15.3K | 4.41M | 59.11% | ↗ |
| 74 | 2015 | John C. Molina Former Chief Financial Officer | 878.0K | — | 2.61M | — | 910.3K | 15.3K | 4.41M | 59.11% | ↗ |
| 75 | 2015 | Terry P. Bayer Former Chief Operating Officer | 644.0K | — | 1.85M | — | 534.1K | 17.8K | 3.05M | 60.76% | ↗ |
| 76 | 2015 | Terry P. Bayer Chief Operating Officer | 644.0K | — | 1.85M | — | 534.1K | 17.8K | 3.05M | 60.76% | ↗ |
| 77 | 2015 | Joseph W. White Chief Accounting Officer | 515.0K | — | 1.46M | — | 384.4K | 15.2K | 2.38M | 61.51% | ↗ |
| 78 | 2015 | Joseph W. White Chief Financial Officer and former Interim Chief Executive Officer | 515.0K | — | 1.46M | — | 384.4K | 15.2K | 2.38M | 61.51% | ↗ |
| 79 | 2015 | Jeff D. Barlow Chief Legal Officer and Secretary | 475.0K | — | 1.22M | — | 354.6K | 31.8K | 2.08M | 58.58% | ↗ |
| 80 | 2014 | Dr. J. Mario Molina President and Chief Executive Officer | 1.05M | — | 6.79M | — | — | 15.2K | 7.85M | 86.44% | ↗ |
| 81 | 2014 | J. Mario Molina, M.D. President and Chief Executive Officer | 1.05M | — | 6.79M | — | — | 15.2K | 7.85M | 86.44% | ↗ |
| 82 | 2014 | John C. Molina Chief Financial Officer | 878.0K | — | 2.52M | — | — | 27.6K | 3.43M | 73.58% | ↗ |
| 83 | 2014 | Terry P. Bayer Chief Operating Officer | 644.0K | — | 1.65M | — | — | 48.9K | 2.34M | 70.43% | ↗ |
| 84 | 2014 | Joseph W. White Chief Accounting Officer | 515.0K | — | 942.9K | — | — | 73.0K | 1.53M | 61.59% | ↗ |
| 85 | 2014 | Jeff D. Barlow Chief Legal Officer and Secretary | 475.0K | — | 754.4K | — | — | 44.9K | 1.27M | 59.20% | ↗ |
| 86 | 2013 | J. Mario Molina, M.D. President and Chief Executive Officer | 1.05M | — | 8.32M | — | 1.28M | 1.25M | 11.90M | 69.89% | ↗ |
| 87 | 2013 | J. Mario Molina President and Chief Executive Officer | 1.05M | 1.28M | 8.32M | — | — | 1.25M | 11.90M | 69.89% | ↗ |
| 88 | 2013 | John C. Molina Chief Financial Officer | 878.0K | — | 4.41M | — | 893.9K | 180.6K | 6.36M | 69.31% | ↗ |
| 89 | 2013 | Terry P. Bayer Chief Operating Officer | 644.0K | — | 2.94M | — | 524.6K | 128.0K | 4.24M | 69.39% | ↗ |
| 90 | 2013 | Joseph W. White Chief Accounting Officer | 515.0K | — | 1.32M | — | 314.6K | 14.4K | 2.17M | 61.05% | ↗ |
| 91 | 2013 | Jeff D. Barlow Chief Legal Officer and Secretary | 425.0K | — | 1.03M | — | 259.6K | 43.0K | 1.76M | 58.57% | ↗ |
| 92 | 2012 | J. Mario Molina, M.D. President and Chief Executive Officer | 935.0K | — | 3.42M | — | — | 594.6K | 4.95M | 69.11% | ↗ |
| 93 | 2012 | J. Mario Molina President and Chief Executive Officer | 935.0K | — | 3.42M | — | — | 594.6K | 4.95M | 69.11% | ↗ |
| 94 | 2012 | John C. Molina Chief Financial Officer | 852.5K | — | 2.05M | — | — | 60.2K | 2.97M | 69.23% | ↗ |
| 95 | 2012 | Terry P. Bayer Chief Operating Officer | 625.0K | — | 1.28M | — | — | 68.3K | 1.97M | 64.86% | ↗ |
| 96 | 2012 | Stephen T. O’Dell SVP Growth and Corporate Development | 379.9K | — | 335.3K | — | — | 470.1K | 1.19M | 28.29% | ↗ |
| 97 | 2012 | Joseph W. White Chief Accounting Officer | 410.0K | — | 603.5K | — | — | 82.0K | 1.10M | 55.09% | ↗ |
| 98 | 2012 | Jeff D. Barlow Chief Legal Officer and Secretary | 396.9K | 116.3K | 503.0K | — | — | 35.5K | 1.05M | 47.83% | ↗ |
| 99 | 2012 | Jeff D. Barlow SVP and General Counsel | 396.9K | 116.3K | 503.0K | — | — | 35.5K | 1.05M | 47.83% | ↗ |
| 100 | 2011 | J. Mario Molina President and Chief Executive Officer | 935.0K | 375.0K | 3.51M | — | — | 125.1K | 4.94M | 70.96% | ↗ |
| 101 | 2011 | John C. Molina Chief Financial Officer | 852.5K | 285.0K | 2.63M | — | — | 19.0K | 3.78M | 69.65% | ↗ |
| 102 | 2011 | James W. Howatt Chief Medical Officer | 87.5K | — | 427.9K | — | — | 1.13M | 1.64M | 26.10% | ↗ |
| 103 | 2011 | Terry P. Bayer Chief Operating Officer | 625.0K | 178.0K | 631.3K | — | — | 92.4K | 1.53M | 41.35% | ↗ |
| 104 | 2011 | Stephen T. O’Dell SVP Growth and Corporate Development | 383.7K | 184.6K | 876.8K | — | — | 20.0K | 1.46M | 60.04% | ↗ |
| 105 | 2011 | Joseph W. White Chief Accounting Officer | 410.0K | 69.0K | 876.8K | — | — | 11.7K | 1.37M | 64.12% | ↗ |
| 106 | 2011 | Jeff D. Barlow SVP and General Counsel | 317.9K | 163.5K | 701.4K | — | — | 49.1K | 1.23M | 56.94% | ↗ |
| 107 | 2011 | Jeff D. Barlow Chief Legal Officer and Secretary | 317.9K | 163.5K | 701.4K | — | — | 49.1K | 1.23M | 56.94% | ↗ |
| 108 | 2010 | J. Mario Molina President and Chief Executive Officer | 850.0K | 1.95M | 339.6K | — | — | 628.4K | 3.77M | 9.01% | ↗ |
| 109 | 2010 | John C. Molina Chief Financial Officer | 775.0K | 1.48M | 339.6K | — | — | 57.9K | 2.65M | 12.80% | ↗ |
| 110 | 2010 | Mark L. Andrews Chief Legal Officer | 305.8K | 145.8K | 296.1K | — | — | 1.68M | 2.43M | 12.20% | ↗ |
| 111 | 2010 | Terry P. Bayer Chief Operating Officer | 500.0K | 250.0K | 296.1K | — | — | 104.3K | 1.15M | 25.74% | ↗ |
| 112 | 2010 | Terry L. Bayer Chief Operating Officer | 500.0K | 250.0K | 296.1K | — | — | 104.3K | 1.15M | 25.74% | ↗ |
| 113 | 2010 | James W. Howatt Chief Medical Officer | 417.0K | 208.5K | 265.6K | — | — | 70.5K | 961.6K | 27.62% | ↗ |
| 114 | 2010 | James Howatt Chief Medical Officer | 417.0K | 208.5K | 265.6K | — | — | 70.5K | 961.6K | 27.62% | ↗ |
| 115 | 2010 | Joseph W. White Chief Accounting Officer | 390.0K | 156.0K | 239.5K | — | — | 62.2K | 847.6K | 28.25% | ↗ |
| 116 | 2010 | Joseph White Chief Accounting Officer | 390.0K | 156.0K | 239.5K | — | — | 62.2K | 847.6K | 28.25% | ↗ |
| 117 | 2010 | Stephen T. O’Dell SVP Growth and Corporate Development | 354.2K | 150.0K | 143.6K | — | — | 32.4K | 680.3K | 21.11% | ↗ |
| 118 | 2010 | Jeff D. Barlow SVP and General Counsel | 263.1K | 124.0K | 121.9K | — | — | 38.0K | 546.9K | 22.29% | ↗ |
| 119 | 2009 | J. Mario Molina President and Chief Executive Officer | 850.0K | — | 292.2K | — | — | 724.1K | 1.87M | 15.66% | ↗ |
| 120 | 2009 | John C. Molina Chief Financial Officer | 775.0K | — | 292.2K | — | — | 122.4K | 1.19M | 24.56% | ↗ |
| 121 | 2009 | Mark L. Andrews Chief Legal Officer | 497.8K | — | 254.7K | — | — | 179.0K | 931.6K | 27.34% | ↗ |
| 122 | 2009 | Terry L. Bayer Chief Operating Officer | 500.0K | — | 254.7K | — | — | 160.6K | 915.4K | 27.83% | ↗ |
| 123 | 2009 | Terry P. Bayer Chief Operating Officer | 500.0K | — | 254.7K | — | — | 160.6K | 915.4K | 27.83% | ↗ |
| 124 | 2009 | James W. Howatt Chief Medical Officer | 417.0K | 52.1K | 228.5K | — | — | 79.3K | 777.0K | 29.41% | ↗ |
| 125 | 2009 | James Howatt Chief Medical Officer | 417.0K | 52.1K | 228.5K | — | — | 79.3K | 777.0K | 29.41% | ↗ |
| 126 | 2009 | Stephen T. O’Dell SVP Growth and Corporate Development | 351.5K | — | 104.9K | — | — | 156.4K | 612.8K | 17.12% | ↗ |
| 127 | 2009 | Joseph White Chief Accounting Officer | 387.2K | — | 187.3K | — | — | 13.8K | 588.3K | 31.84% | ↗ |
| 128 | 2009 | Joseph W. White Chief Accounting Officer | 387.2K | — | 187.3K | — | — | 13.8K | 588.3K | 31.84% | ↗ |
| 129 | 2008 | J. Mario Molina President and Chief Executive Officer | 850.0K | 800.8K | 493.7K | — | — | 73.1K | 2.22M | 22.26% | ↗ |
| 130 | 2008 | John C. Molina Chief Financial Officer | 775.0K | 547.6K | 493.7K | — | — | 80.7K | 1.90M | 26.03% | ↗ |
| 131 | 2008 | Terry L. Bayer Chief Operating Officer | 465.0K | 162.5K | 430.4K | — | — | 14.0K | 1.07M | 40.15% | ↗ |
| 132 | 2008 | Mark L. Andrews Chief Legal Officer | 430.0K | 182.8K | 402.0K | — | — | 20.7K | 1.04M | 38.82% | ↗ |
| 133 | 2008 | James Howatt Chief Medical Officer | 394.8K | 135.5K | 386.1K | — | — | 12.4K | 928.9K | 41.57% | ↗ |
| 134 | 2008 | Joseph White Chief Accounting Officer | 300.0K | 63.6K | 177.2K | — | — | 70.4K | 608.6K | 29.12% | ↗ |
| 135 | 2007 | J. Mario Molina President and Chief Executive Officer | 775.0K | — | — | 594.1K | — | 172.4K | 1.54M | 38.54% | ↗ |
| 136 | 2007 | John C. Molina Chief Financial Officer | 700.0K | — | — | 594.1K | — | 54.6K | 1.35M | 44.05% | ↗ |
| 137 | 2007 | Mark L. Andrews Chief Legal Officer | 430.0K | 154.8K | 173.8K | 181.5K | — | 36.4K | 976.6K | 36.39% | ↗ |
| 138 | 2007 | Terry L. Bayer Chief Operating Officer | 405.0K | 155.2K | 173.8K | 181.5K | — | 18.0K | 933.6K | 38.06% | ↗ |
| 139 | 2007 | James Howatt Chief Medical Officer | 201.9K | 128.7K | 175.9K | 185.7K | — | 4.9K | 697.2K | 51.87% | ↗ |
| 140 | 2006 | J. Mario Molina , President and Chief Executive Officer | 751.9K | — | — | — | — | 55.3K | 1.33M | 0.00% | ↗ |
| 141 | 2006 | Mark L. Andrews , Chief Legal Officer | 430.0K | — | — | — | — | 10.4K | 935.0K | 0.00% | ↗ |
| 142 | 2006 | John C. Molina , Chief Financial Officer | 656.9K | — | — | — | — | 12.4K | 879.7K | 0.00% | ↗ |
| 143 | 2006 | Terry Bayer , Chief Operating Officer | 372.5K | — | — | — | — | 12.4K | 843.4K | 0.00% | ↗ |
| 144 | 2006 | William Bracciodieta , Chief Medical Officer | 372.5K | — | — | — | — | 4.8K | 791.0K | 0.00% | ↗ |
| 145 | 2005 | Mark L. Andrews, Esq. Chief Legal Officer, General Counsel and Corporate Secretary | 430.0K | 143.3K | 133.2K | 12.0K | — | 9.4K | 727.9K | 19.95% | ↗ |
| 146 | 2005 | J. Mario Molina, M.D. Chief Executive Officer, President, and Chairman | 675.0K | — | — | — | — | 9.4K | 684.4K | 0.00% | ↗ |
| 147 | 2005 | Terry Bayer Chief Operating Officer | 350.0K | 143.3K | — | 21.0K | — | 9.0K | 523.3K | 4.01% | ↗ |
| 148 | 2005 | John C. Molina, J.D. Chief Financial Officer, Treasurer and Director | 451.0K | — | — | — | — | 8.9K | 459.9K | 0.00% | ↗ |
| 149 | 2005 | M. Martha Bernadett, M.D. Executive Vice President, Research and Development | 300.0K | — | — | — | — | 8.9K | 308.9K | 0.00% | ↗ |
| 150 | 2004 | J. Mario Molina, M.D. Chief Executive Officer, President, and Chairman | 642.8K | — | — | — | — | 9.0K | 651.9K | 0.00% | ↗ |
| 151 | 2004 | George S. Goldstein, Ph.D. Executive Vice President, Health Plan Operations, Chief Operating Officer and Director | 454.0K | 50.0K | — | 30.0K | — | 46.3K | 580.2K | 5.17% | ↗ |
| 152 | 2004 | Mark L. Andrews, Esq. Chief Legal Officer, General Counsel and Corporate Secretary | 399.1K | 75.0K | — | 30.0K | — | 9.0K | 513.1K | 5.85% | ↗ |
| 153 | 2004 | John C. Molina, J.D. Executive Vice President, Financial Affairs, Chief Financial Officer, Treasurer and Director | 435.1K | 50.0K | — | — | — | 8.7K | 493.8K | 0.00% | ↗ |
| 154 | 2004 | Mark L. Andrews, Esq. Executive Vice President, Legal Affairs, General Counsel and Corporate Secretary | 399.1K | 50.0K | — | 30.0K | — | 9.0K | 488.1K | 6.15% | ↗ |
| 155 | 2004 | John C. Molina, J.D. Chief Financial Officer, Treasurer and Director | 435.1K | — | — | — | — | 8.7K | 443.8K | 0.00% | ↗ |
| 156 | 2004 | Terry Bayer Chief Operating Officer | 87.5K | — | 319.7K | — | — | 74.00 | 407.3K | 78.50% | ↗ |
| 157 | 2004 | M. Martha Bernadett, M.D Executive Vice President, Development | 317.3K | 26.0K | — | — | — | 8.7K | 352.0K | 0.00% | ↗ |
| 158 | 2004 | M. Martha Bernadett, M.D. Executive Vice President, Research and Development | 317.3K | — | — | — | — | 8.7K | 326.0K | 0.00% | ↗ |
| 159 | 2003 | George S. Goldstein, Ph.D. Executive Vice President, Health Plan Operations, Chief Operating Officer and Director | 398.4K | 161.0K | — | — | — | 15.8K | 575.1K | 0.00% | ↗ |
| 160 | 2003 | J. Mario Molina, M.D. Chief Executive Officer, President, and Chairman | 500.0K | 50.0K | — | — | — | 9.6K | 559.6K | 0.00% | ↗ |
| 161 | 2003 | Mark L. Andrews, Esq. Executive Vice President, Legal Affairs, General Counsel and Corporate Secretary | 323.4K | 129.3K | — | — | — | 9.0K | 461.7K | 0.00% | ↗ |
| 162 | 2003 | John C. Molina, J.D. Chief Financial Officer, Treasurer and Director | 400.0K | 50.0K | — | — | — | 11.1K | 461.1K | 0.00% | ↗ |
| 163 | 2003 | John C. Molina, J.D. Executive Vice President, Financial Affairs, Chief Financial Officer, Treasurer and Director | 400.0K | — | — | — | — | 11.1K | 411.1K | 0.00% | ↗ |
| 164 | 2003 | Mark L. Andrews, Esq. Chief Legal Officer, General Counsel and Corporate Secretary | 323.4K | 50.0K | — | — | — | 9.0K | 382.4K | 0.00% | ↗ |
| 165 | 2003 | M. Martha Bernadett, M.D. Executive Vice President, Research and Development | 298.1K | 26.0K | — | — | — | 8.5K | 332.5K | 0.00% | ↗ |
| 166 | 2003 | M. Martha Bernadett, M.D Executive Vice President, Development | 298.1K | — | — | — | — | 8.5K | 306.6K | 0.00% | ↗ |
| 167 | 2002 | J. Mario Molina, M.D. Chief Executive Officer, President and Chairman | 567.3K | 500.0K | — | — | — | 11.6K | 1.08M | 0.00% | ↗ |
| 168 | 2002 | J. Mario Molina, M.D. Chief Executive Officer, President, and Chairman | 500.0K | 500.0K | — | — | — | 11.6K | 1.01M | 0.00% | ↗ |
| 169 | 2002 | John C. Molina, J.D. Executive Vice President, Financial Affairs, Chief Financial Officer, Treasurer and Director | 441.5K | 278.6K | — | — | — | 11.2K | 731.4K | 0.00% | ↗ |
| 170 | 2002 | George S. Goldstein, Ph.D. Executive Vice President, Health Plan Operations, Chief Operating Officer and Director | 389.7K | 117.0K | — | 160.0K | — | 17.6K | 684.3K | 23.38% | ↗ |
| 171 | 2002 | George S. Goldstein, Ph.D. Executive Vice President, Health Plan Operations and Director | 406.6K | 161.0K | — | — | — | 17.6K | 585.2K | 0.00% | ↗ |
| 172 | 2002 | Mark L. Andrews, Esq. Executive Vice President, Legal Affairs, General Counsel and Corporate Secretary | 328.3K | 80.4K | — | 72.0K | — | 11.8K | 492.5K | 14.62% | ↗ |
| 173 | 2002 | M. Martha Bernadett, M.D. Executive Vice President, Development | 281.0K | 99.0K | — | — | — | 13.9K | 393.8K | 0.00% | ↗ |
| 174 | 2002 | M. Martha Bernadett, M.D Executive Vice President, Development | 281.0K | 99.0K | — | — | — | 13.9K | 393.8K | 0.00% | ↗ |
| 175 | 2001 | George S. Goldstein, Ph.D. Executive Vice President, Health Plan Operations, Chief Operating Officer and Director | 327.7K | 117.0K | — | 1.37M | — | 15.9K | 1.83M | 74.79% | ↗ |
| 176 | 2001 | George S. Goldstein, Ph.D. Executive Vice President, Health Plan Operations and Director | 327.7K | 117.0K | — | 1.37M | — | 15.9K | 1.83M | 74.79% | ↗ |
| 177 | 2001 | Mark L. Andrews, Esq. Executive Vice President, Legal Affairs, General Counsel and Corporate Secretary | 287.3K | 80.4K | — | 614.8K | — | 14.3K | 996.8K | 61.68% | ↗ |
| 178 | 2001 | J. Mario Molina, M.D. Chief Executive Officer, President, and Chairman | 400.0K | 250.0K | — | — | — | 14.3K | 664.3K | 0.00% | ↗ |
| 179 | 2001 | J. Mario Molina, M.D. Chief Executive Officer, President and Chairman | 400.0K | 250.0K | — | — | — | 14.3K | 664.3K | 0.00% | ↗ |
| 180 | 2001 | John C. Molina, J.D. Executive Vice President, Financial Affairs, Chief Financial Officer, Treasurer and Director | 250.3K | 175.0K | — | — | — | 14.2K | 439.5K | 0.00% | ↗ |
| 181 | 2001 | M. Martha Bernadett, M.D Executive Vice President, Development | 232.9K | 128.7K | — | — | — | 13.9K | 375.4K | 0.00% | ↗ |
| 182 | 2001 | M. Martha Bernadett, M.D. Executive Vice President, Development | 198.0K | 128.7K | — | — | — | 13.9K | 340.6K | 0.00% | ↗ |
| 183 | 2000 | J. Mario Molina, M.D. Chief Executive Officer, President and Chairman | 300.0K | 300.0K | — | — | — | 14.0K | 614.0K | 0.00% | ↗ |
| 184 | 2000 | George S. Goldstein, Ph.D. Executive Vice President, Health Plan Operations and Director | 276.5K | 98.8K | — | — | — | 14.0K | 389.3K | 0.00% | ↗ |
| 185 | 2000 | John C. Molina, J.D. Executive Vice President, Financial Affairs, Chief Financial Officer, Treasurer and Director | 250.3K | 94.0K | — | — | — | 14.0K | 358.3K | 0.00% | ↗ |
| 186 | 2000 | Mark L. Andrews, Esq. Executive Vice President, Legal Affairs, General Counsel and Corporate Secretary | 246.7K | 73.9K | — | — | — | 12.5K | 333.1K | 0.00% | ↗ |
| 187 | 2000 | M. Martha Bernadett, M.D. Executive Vice President, Development | 198.0K | 59.4K | — | — | — | 14.0K | 271.4K | 0.00% | ↗ |
| 188 | 1996 | J. Mario Molina, M.D., 49 | — | — | — | — | — | — | — | — | ↗ |
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Joseph Michael Zubretsky | President, Chief Executive Officer & Director | 2M | male |
| Mark Lowell Keim | Senior EVice President, Chief Financial Officer & Treasurer | 1M | male |
| James Edwin Woys | Senior EVP & COO | 856.4K | male |
| Maurice Sebastian Hebert | Chief Accounting Officer | 835.7K | male |
| Jeffrey Don Barlow | Chief Legal Officer & Corporate Secretary | 736.0K | male |
| Debra Jean Bacon | Executive Vice President of Medicaid | 723.0K | female |
| Joann Zarza-Garrido | Vice President of Compliance | — | female |
| Jeffrey Geyer | Head of Investor Relations | — | — |
| Keith Wilson | Chief Medical Officer | — | — |
| Larry D. Anderson | Executive Vice President & Chief Human Resources Officer | — | male |
No Senate trading activity found for this company.
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2025-11-12 | 2025-12-15 | Gilbert Cisneros | CA31 | — | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2025-09-29 | 2025-10-03 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-09-04 | 2025-10-08 | Byron Donalds | FL19 | Spouse | Sale | $1,001 - $15,000 | ↗ |
| 2025-08-05 | 2025-09-12 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-05-30 | 2025-06-06 | Gilbert Cisneros | CA31 | — | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2025-05-30 | 2025-06-09 | Gilbert Cisneros | CA31 | — | Sale | $1,001 - $15,000 | ↗ |
| 2025-05-15 | 2025-06-10 | Rob Bresnahan | PA08 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-04-29 | 2025-05-07 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2024-09-09 | 2024-10-08 | Ro Khanna | CA17 | Spouse | Sale | $1,001 - $15,000 | ↗ |
| 2023-07-12 | 2023-08-13 | Daniel Goldman | NY10 | — | Sale | $15,001 - $50,000 | ↗ |
| 2023-06-15 | 2023-07-12 | Earl Blumenauer | OR03 | Spouse | Purchase | $15,001 - $50,000 | ↗ |
| 2023-05-23 | 2023-06-12 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2023-04-10 | 2023-05-19 | Daniel Goldman | NY10 | — | Purchase | $15,001 - $50,000 | ↗ |
| 2023-03-24 | 2023-04-07 | Ro Khanna | CA17 | — | Sale | $1,001 - $15,000 | ↗ |
| 2023-03-14 | 2023-04-07 | Ro Khanna | CA17 | Spouse | Sale | $1,001 - $15,000 | ↗ |
| 2023-02-10 | 2023-03-08 | Ro Khanna | CA17 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2023-01-11 | 2023-02-07 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2023-01-09 | 2023-02-07 | Ro Khanna | CA17 | Spouse | Sale | $1,001 - $15,000 | ↗ |
| 2022-12-06 | 2023-01-03 | Ro Khanna | CA17 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2022-05-23 | 2022-06-10 | Ro Khanna | CA17 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MOH
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
